Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and Alloxan Diabetes

angiotensin ii has been researched along with Alloxan Diabetes in 322 studies

Research

Studies (322)

TimeframeStudies, this research(%)All Research%
pre-199029 (9.01)18.7374
1990's56 (17.39)18.2507
2000's116 (36.02)29.6817
2010's106 (32.92)24.3611
2020's15 (4.66)2.80

Authors

AuthorsStudies
Cheng, C; Cheng, J; Hao, P; Sui, W; Wang, X; Xing, Y; Xue, F; Zhang, C; Zhang, J; Zhang, M; Zhang, Y1
Abderrahim, N; Adriani, W; Ahmed, F; Algarra, M; Amor, HB; Andreasi, V; Bailey, RL; Bettinardi, V; Bezzi, C; Bithe, SA; Boumnijel, I; Burr, SE; Cadmus, P; Calcaprina, B; Canevari, C; Catalfamo, B; Chen, J; Chen, X; Chen, Y; Clements, WH; Cornick, J; Cotton, SJ; De Cobelli, F; Djellabi, R; Falconi, M; Ghezzo, S; Gianolli, L; Guarnaccia, A; Guo, X; Hart, JD; Hasan, MM; Head-Gordon, M; Iwasaki, Y; Kalua, K; Kong, X; Laviola, G; Li, L; Li, M; Liu, M; Mao, Y; Mapelli, P; Meleke, H; Messina, A; Miller, WH; Muffatti, F; Neher, B; Palumbo, D; Partelli, S; Peláez, D; Pepe, M; Picchio, M; Presotto, L; Ranville, J; Samanes Gajate, AM; Samikwa, L; Schiavo Lena, M; Scifo, P; Shu, H; Soto, J; Sun, W; Talbot, JJ; Tu, J; Vaquer, F; Weng, L; Wu, J; Xu, T; Zhang, D; Zhao, B; Zhao, K; Zhao, Y1
Azushima, K; Haruhara, K; Kato, I; Kawase, W; Kinguchi, S; Kobayashi, R; Kurotaki, D; Ohashi, K; Ohki, K; Suzuki, T; Tamura, K; Tamura, T; Tsuboi, N; Uneda, K; Wakui, H; Yamaji, T; Yamashita, A; Yokoo, T1
Nishi, H1
Hu, TT; Tang, QZ; Wan, Y; Wu, QQ; Xie, QW; Yao, Q; Yuan, Y; Zhao, JH1
Clahsen-van Groningen, MC; Cruz-López, EO; Danser, AHJ; Domenig, O; Foster, D; Garrelds, IM; Kasper, A; Nioi, P; Poglitsch, M; Ren, L; Rooney, T; Uijl, E; van Veghel, R; Zlatev, I1
Dias-Pereira, P; Duarte-Araújo, M; Esteves-Monteiro, M; Ferreira-Duarte, M; Menezes-Pinto, D; Morato, M1
Alipourfard, I; Alizadeh-Fanalou, S; Babaei, M; Bahreini, E; Kalantari-Hesari, A; Khomari, F; Kiani, B; Mirzaei, F; Yarahmadi, S1
Abo-Saif, AA; El-Sayed El-Daly, M; Moustafa Ahmed, Y; Shehata Messiha, BA1
Al-Shabrawey, M; Hsiao, G; Ibrahim, AS; Tawfik, A; Wang, MH1
Abbas, AM; Badi, RM; Bashir, SO; Mohammed, ME; Morsy, MD; Osman, OM; Saeed, AM1
Mosquera, J; Muñoz, N; Pedreañez, A1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Gaikwad, AB; Sharma, N1
Bulut, H; Elibol, B; Kilic, A; Meral, I; Sahin, G; Ustunova, S1
Keshawy, MM; Makary, S; Tawfik, MK1
Gong, WQ; Huang, WC; Liang, Y; Liu, B; Yang, CM; Ye, XL; Zheng, YT1
Islam, MZ; Miyamoto, A; Shiraishi, M; Van Dao, C1
Buggs, J; Jiang, S; Liu, R; Qu, HY; Song, J; Wang, L; Wei, J; Zhang, J1
Fang, WJ; Shyu, KG; Wang, BW1
Dong, J; Guo, C; Liao, L; Mou, Y; Zhang, Y; Zhang, Z; Zhao, J; Zhou, X1
Allen, TJ; Bach, LA; Biros, E; Chai, Z; Chow, B; Cooper, ME; Dai, A; Du, XJ; Golledge, J; Huynh, P; Kiriazis, H; Li, J; Nataatmadja, M; Tu, Y; Walker, P; West, M; Wilkinson-Berka, JL; Wu, T1
Aziz, NM; El-Tahawy, NF; Elbassuoni, EA1
Ji, W; Jia, L; Li, H; Zhang, Y1
Cui, ZH; Hao, Q; Li, ZH; Liu, TT; Yang, W; Zhang, Y1
Abdulla, MH; Afzal, S; Akhtar, S; Binti Abdullah, NA; Eseyin, OA; Johns, EJ; Sattar, MA1
Anguiano, L; Clotet-Freixas, S; Gimeno, J; Konvalinka, A; Palau, V; Pascual, J; Riera, M; Soler, MJ1
Angelis, K; Dartora, DR; Evangelista, FS; Fiorino, P; Flues, K; Irigoyen, MC; Moraes, OA; Mostarda, C; Rodrigues, B; Scapini, KB1
Bernstein, EA; Bernstein, KE; Cao, DY; Eriguchi, M; Fuchs, S; Giani, JF; Gonzalez-Villalobos, RA; Khan, Z; McDonough, AA; Toblli, JE; Veiras, LC1
Nemoto, W1
Furukawa, T; Nakagawasai, O; Nemoto, W; Ogata, Y; Shimoyama, S; Tan-No, K; Ueno, S; Yamagata, R1
Ding, W; Gan, L; Gao, L; He, H; Li, X; Li, Y; Liu, J; Ou, S; Wang, M; Wu, W1
Liu, Y; Ma, R; Song, L; Xu, Y; Yao, D; Zhang, D; Zhou, H1
Arad, M; Aravot, D; Hochhauser, E; Kornwoski, R; Nudelman, V; Peterson, SJ; Shainberg, A; Waldman, M; Zemel, R1
Cha, SK; Chung, CH; Kang, JS; Kim, JH; Lee, ES; Lee, EY; Lee, JH; Lee, SJ; Son, SS1
Corrêa, FM; de Oliveira, AM; Gomes, MS; Pernomian, L; Ramalho, LN; Restini, CB1
Akhtar, S; Benter, IF; El-Hashim, AZ; Kilarkaje, N; Makki, B; Yousif, MH1
Csohány, R; Kosik, A; Prókai, A; Szabó, JA1
Gong, X; Li, G; Li, Y; Song, Y; Yuan, L1
Miao, J; Wang, S; Zhang, W; Zhang, Y1
Chen, M; Gao, H; Liu, Y; Xie, CG; Zhuang, C1
Chen, CX; Dong, Z1
Batlle, D; Burns, KD; Garcia-Halpin, L; Maier, C; Sowers, K; Wysocki, J; Ye, M1
Chen, JR; Wu, LY; Yang, HY; Yeh, WJ1
Liu, X; Patel, KP; Zheng, H1
Chen, X; Diao, TY; Gu, SS; Pan, H; Wong, MS; Zhang, FY; Zhang, Y1
Ma, C; Wang, SS; Wang, YX; Zhang, W; Zhang, YS1
Chen, Y; Gao, H; Liu, Z; Qiu, S; Shen, T; Sun, Y; Wen, X; Zhao, Y1
Carter, A; He, Y; Hébert, RL; Kennedy, CRJ; Nasrallah, R; Thibodeau, JF; Touyz, R1
Baker, KM; Chandel, N; Kumar, R; Seqqat, R; Thomas, CM; Yong, QC1
Chen, RC; Ma, XJ; Sun, GB; Sun, X; Sun, XB; Wang, M; Yang, LJ; Yang, ZH1
Cai, L; Fang, Q; Huang, Y; Liang, G; Miao, L; Pan, Y; Peng, K; Sun, Y; Tong, C; Wang, Y; Wang, Z; Zhao, Y1
Achard, JM; Botelle, L; Clere, N; Faure, S; Javellaud, J; Nasser, M; Oudart, N1
Bódi, N; Kovacs, G; Nyengaard, JR; Razga, Z; Talapka, P1
Baltissen, MP; Berden, JH; Hoenderop, JG; Nijenhuis, T; Sonneveld, R; van der Vlag, J; Verkaart, SA; Wetzels, JF1
Bai, X; Li, X; Tian, J; Zhou, Z1
Guo, T; Hao, P; Kong, J; Li, D; Meng, X; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y1
Duan, XC; Fang, ZH; Gao, JR; Wang, YZ; Wu, J; Xia, LZ; Yao, XM1
Gao, S; Liang, X; Liu, J; Liu, W; Wan, Z; Wu, Y; Yuan, Z; Zhuo, X1
Bobadilla-Lugo, RA; Bracho-Valdés, I; Ibarra-Barajas, M; Tufiño, C; Villanueva-López, C1
Coffman, TM; Dolber, PC; Fraser, MO; Gurley, SB; Jin, H; Nassar, R1
Chang, YH; Chen, JW; Chien, S; Chu, PH; Huang, PH; Li, SY; Lin, CC; Lin, SJ; Lin, TP; Schmid-Schönbein, GW; Tarng, DC; Yang, AH; Yang, MH; Yang, WC1
Bagal, S; Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A1
Cismowski, MJ; Galantowicz, ML; Husarek, KE; Katz, PS; Lucchesi, PA; Trask, AJ1
Abadir, PM; Siragy, HM1
Hong, E; Huang, F; Reséndiz-Albor, AA; Rodriguez, JE; Romero-Nava, R; Ruiz-Hernandéz, A; Sánchez-Muñoz, F; Villafaña, S1
Chen, F; Chen, X; Deng, Y; Ding, D; Du, Y; Hu, X; Liao, Y; Qiu, Z; Wang, L; Wang, M; Wang, S; Wu, H; Yan, S; Yang, S; Yu, X; Zhang, H; Zhou, Y; Zhou, Z1
Chodavarapu, H; Lazartigues, E; Pedersen, KB; Porretta, C; Robinson, LK1
Huang, X; Kim, YC; Liu, DH; Lu, HL; Meng, XM; Xu, WX; Zhang, CM1
Achike, FI; Kunasegaran, T; Murugan, DD; Mustafa, MR1
Cheng, YL; Wang, WN; Xu, HZ; Xu, ZG; Zhang, YY1
da Silva, CH; de Oliveira, AM; do Prado, AF; Gomes, MS; Moreira, JD; Moreira, RP; Pernomian, L1
Al-Salami, H; Elahy, M; Lam, V; Mamo, JC; Mooranian, A; Negrulj, R; Takechi, R1
Ren, YN; Tao, SJ; Wu, YJ; Zhao, MQ; Zheng, SG1
Han, SH; Kang, HY; Kang, SW; Kim, S; Nam, BY; Oh, HJ; Paeng, J; Park, J; Park, JT; Ryu, DR; Um, JE; Yoo, TH1
Han, D; Rong, C; Wang, K; Zhang, Y1
Nakagawasai, O; Nemoto, W; Ogata, Y; Tadano, T; Tan-No, K; Yamagata, R1
Georgiev, T; Hadzhibozheva, P; Kalfin, R; Tolekova, A1
Batlle, D; David, NV; Fogo, A; Kanwar, Y; Khattab, AM; Martin, A; Osborn, M; Wysocki, J; Ye, M1
Hong, E; Huang, F; Reséndiz-Albor, AA; Rodríguez, JE; Romero-Nava, R; Rosales-Cruz, E; Villafaña, S1
Li, XL; Sha, NN; Shi, Q; Shu, B; Wang, XL; Wang, YJ; Wong, MS; Xiao, HH; Zhang, Y; Zhao, YJ1
Gómez, O; Molina-Holgado, E; Uceda, ER; Vera, ME; Vieitez, P1
Achike, FI; Dharmani, M; Mustafa, MR; Sim, MK3
Khraibi, AA; Yu, T1
Ihm, CG; Jeong, KH; Lee, SH; Lee, TW; Lim, SJ; Moon, JY1
Cai, L; Hein, DW; Li, X; Marshall, JP; Prabhu, SD; Xiang, X; Zhou, G1
Abadir, PM; Abdel-Rahman, EM; Siragy, HM1
Degrell, P; Fekete, A; Prokai, A; Ronai, K; Rosta, K; Rusai, K; Ruzicska, E; Somogyi, A; Szabo, AJ; Toth, M; Tulassay, T; Vegh, E; Ver, A; Wagner, L1
Anand-Srivastava, MB; Descorbeth, M1
Baker, KM; Khode, R; Kumar, R; Le, B; Singh, VP1
Lu, J; Sun, L; Yu, XJ; Zang, WJ; Zhang, CH1
Chu, XY; Li, M; Lin, L; Ni, Q; Wang, ZL1
Kamata, K; Kobayashi, T; Matsumoto, T; Nogami, T; Taguchi, K1
Gul, R; Jang, KY; Kim, SY; Kim, UH; Park, KH1
Cho, CS; Kim, JH; Kim, KW; Yu, YS1
Bursell, SE; Chilcote, TJ; Clermont, AC; Feener, EP; Phipps, JA; Sinha, S1
Al-Maghrebi, M; Benter, IF; Diz, DI1
Jung, KH; Kim, SK; Lee, BC1
Fukumoto, M; Hayashi, T; Ikeda, T; Jin, D; Kitaura, Y; Miyazaki, M; Oku, H; Sugiyama, T; Takai, S1
De Geest, B; Egorova, M; Jacobs, F; Lorenz, M; Meloni, M; Schultheiss, HP; Spillmann, F; Stangl, V; Tschöpe, C; Van Linthout, S1
Akhtar, S; Benter, IF; Dahly-Vernon, AJ; Dunn, KM; Roman, RJ; Yousif, MH1
Arbeeny, C; Chen, Y; Deb, DK; Kong, J; Li, G; Li, YC; Ning, G; Sabbagh, Y; Strugnell, S; Wang, Y; Zhang, Y; Zhang, Z1
Alfarano, C; Cerbai, E; Failli, P; Franchi-Micheli, S; Mannucci, E; Mugelli, A; Raimondi, L1
Cai, L; Liu, Q; Tan, Y; Wang, G; Wang, Y; Xu, J; Xu, W1
Cho, WH; Choi, HS; Hur, SH; Jung, GS; Kim, BW; Kim, HS; Kim, HT; Kim, JG; Kim, MK; Lee, HJ; Lee, IK; Lee, KM; Lee, KU; Lim, JO; Park, KG1
Jin, D; Miyazaki, M; Ohzu, M; Takai, S; Tanaka, K1
Cheng, G; Li, S; Liu, HY; Wang, LL; Zhang, B1
Hong, E; Villafaña, S1
He, M; Lu, LM; Shao, Y; Wang, XF; Xue, H; Yao, T; Yu, C; Zhang, L; Zhou, L1
Kasture, S; Mohan, M; Waghulde, H1
Akata, T; Hoka, S; Izumi, K; Shirozu, K; Yoshino, J1
Collins, AR; Hsueh, WA; Kim, J; Liu, J; Nguyen, L; Nicholas, SB; Ren, Y1
Chai, Q; He, T; Katusic, ZS; Lee, HC; Lu, T; Wang, RX; Wang, XL; Zhang, DM1
Iwamoto, Y; Maekawa, Y; Ohishi, M; Ohnishi, M; Rakugi, H; Shiota, A; Takeda, M; Tatara, Y; Yamamoto, K1
Cheng, Q; Leung, PS1
Bokuda, K; Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Mizuguchi, Y; Narita, T; Sakoda, M; Seki, Y1
Kim, SH; Oh, YB; Park, BH; Shah, A; Shan, G; Song, CH1
Appelhoff, RJ; Endre, ZH; Findon, G; Hill, JV1
Asagami, T; Dalman, RL; Dua, MM; Miyama, N; Schultz, GM; Sho, E; Sho, M; Yeung, JJ1
Fujii, M; Inoguchi, T; Kobayashi, K; Maeda, Y; Sasaki, S; Takayanagi, R; Zheng, J1
Hara, T; Hitomi, H; Ihara, G; Ito, S; Kiyomoto, H; Kobori, H; Kohno, M; Mori, T; Nagai, Y; Nakano, D; Nishiyama, A; Ohashi, N; Pelisch, N1
Chen, WC; Kanwar, YS; Ling, GH; Liu, FY; Liu, H; Liu, YH; Ma, MM; Nie, J; Peng, YM; Sun, L; Tang, WB; Xia, YC; Xiao, L; Zhan, M; Zhu, XJ1
Bidasee, KR; Mayhan, WG; Patel, KP; Zheng, H1
Cai, L; Guo, QY; Li, B; Liu, N; Ma, FZ; Miao, LN; Xu, ZG1
Aizawa, Y; Giridharan, VV; Harima, M; Kodama, M; Lakshmanan, AP; Sari, FR; Soetikno, V; Thandavarayan, RA; Watanabe, K1
Akula, K; Bagi, Z; Cassuto, J; Feher, A; Kaley, G; Koller, A; Labinskyy, N1
Bobadilla Lugo, RA; Fernandez-Vallín, E; Lopez Sanchez, P; Velazquez-Roman, JA; Villafaña, S1
Chen, LH; Cheng, H; Hao, SY; Lin, DZ; Ren, M; Yan, L; Yang, C; Zhu, P1
Cai, L; Epstein, PN; Li, X; Ma, Z; Miao, L; Tan, Y; Wang, Y; Yang, J; Yin, X; Yu, J; Zhao, F; Zheng, S; Zheng, Y1
Abboud, HE; Ding, M; Ding, Y; Gorin, Y; Graham, S; Lee, DY; Ma, R; Shi, H1
Sharma, PL; Singh, K; Singh, T1
Casarini, DE; De Angelis, K; de Oliveira, EM; Fernandes, T; Irigoyen, MC; Malfitano, C; Mostarda, C; Oliveira, EM; Pazzine, M; Ronchi, FA; Rosa, K; Wichi, RB1
Li, YL; Zheng, H1
Chen, J; Chopp, M; Cui, X; Cui, Y; Liu, X; Lu, M; Roberts, C; Shehadah, A; Yan, T; Ye, X; Zacharek, A1
Ban, N; Kubota, S; Kurihara, T; Ozawa, Y; Sasaki, M; Tsubota, K; Yuki, K1
Leung, KK; Leung, PS; Liang, J; Ma, MT1
Baraldi Araujo Restini, C; Maria de Oliveira, A; Naira Zambelli Ramalho, L; Pernomian, L; Renato Tirapelli, C; Santos Gomes, M1
Abe, J; Chang, E; Fujiwara, K; Heo, KS; Le, NT; Lee, H; Lu, Y; McClain, C; Molina, CA; Morrell, C; Oikawa, M; Patterson, C; Shishido, T; Takei, Y; Taunton, J; Tournier, C; Wang, X; Woo, CH; Yan, C; Yang, J1
Almeida, I; Brosnihan, KB; Chappell, MC; Gilliam-Davis, S; Lindsey, SH; Yamaleyeva, LM1
Hernández-Fonseca, JP; Mosquera, J; Pedreañez, A; Peña, C; Rincón, J; Vargas, R; Viera, N1
Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH1
Fan, ZD; Gan, XB; Gao, XY; Xiong, XQ; Zhang, L; Zhu, GQ1
Cooper, ME; Du, XJ; Head, GA; Kiriazis, H; Nguyen-Huu, TP; Pickering, R; Thomas, MC; Tikellis, C; Tsorotes, D1
Haji, AA; Kaiser, A; Li, X; Parhat, K; Wei, YY; Yan, D1
Katkhuda, R; Norris, AW; Peterson, ES; Roghair, RD; Scholz, TD; Segar, JL1
Cahill, C; Geraldes, P; Hiraoka-Yamomoto, J; King, GL; Kitada, M; Li, C; Li, Q; Matsumoto, M; Mima, A; Mizutani, K; Nishikawa, S; Park, K; Rask-Madsen, C1
Albino-Teixeira, A; Fasching, A; Morato, M; Palm, F; Patinha, D; Pinho, D1
Fan, YY; Hitomi, H; Huang, W; Kobori, H; Li, P; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Sun, YX; Zhang, L; Zhi, N; Zhu, B1
Chen, X; Liu, SK; You, JL; Zhou, M1
Cachofeiro, V; Cediel, E; de las Heras, N; Lahera, V; Navarro-Cid, J; Sanz-Rosa, D; Vázquez-Cruz, B1
Cachofeiro-Ramos, V; Cediel, E; Lahera-Julia, V; Vázquez-Cruz, B1
Cheng, X; Leung, SW; Lim, SL; Pang, CC1
Maliszewska-Scislo, M; Rossi, NF; Scislo, TJ1
Wu, XY; Zhong, HJ; Zhou, M1
Aoki, M; Higaki, J; Komai, N; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Ogihara, T; Tomita, N1
Liu, XF; Shimoni, Y2
Jandhyala, BS; Tallam, LS1
Akamine, E; Carvalho, MH; Fortes, ZB; Nigro, D; Passaglia, RC; Toledo, DP1
Brands, MW; Cloud, LJ1
Ciccone, E; Deelman, L; Hajnoczky, G; Henning, R; Hu, T; Kurz, B; Ma, X; Madesh, M; Sharma, K; Siva, S; Wang, L; Zhu, Y1
Kamata, K; Kaneda, A; Kobayashi, T1
Boner, G; Erman, A; Gafter, U; Natif, N; Sclarovsky-Benjaminov, F; Sulkes, J; Van Dijk, DJ1
Elías, MM; García, VM; Monasterolo, LA1
Aberle, NS; Anversa, P; Kajstura, J; Norby, FL; Ren, J1
Cao, Z; Cooper, ME; Lassila, M; Zhang, X1
Dosenko, VIe; Iahupol's'kyĭ, LM; Moĭbenko, OO; Pyvovar, SM; Strutyns'kyĭ, RB1
Chung, CH; Hong, SY; Kim, MJ; Lee, EY; Shim, MS; Shin, YG1
Foldes, G; Lako-Futo, Z; Ruskoaho, H; Ruzicska, E; Sarman, B; Somogyi, A; Szenasi, G; Toth, M; Tulassay, Z; Wellmann, J1
Awad, AS; Carey, RM; Siragy, HM; Webb, RL2
Arun, KH; Kaul, CL; Poduri, R1
Hayashi, M; Ichihara, A; Inagami, T; Ishida, Y; Kaneshiro, Y; Koura, Y; Nabi, AH; Nakagawa, T; Nishiyama, A; Okada, H; Saruta, T; Suzuki, F; Tada, Y; Uddin, MN1
Arun, KH; Kaul, CL; Ramarao, P2
Xie, XW; Zhao, P1
Adler, SG; Cheon Park, H; Ha, SK; Han, DS; Kang, SW; Natarajan, R; Ryu, DR; Xu, ZG; Yoo, TH1
Leehey, DJ; Singh, AK; Singh, R1
Davidson, WR; Liu, ML; McCue, P; Sharma, K; Williams, KJ; Xu, X; Zhu, Y1
Inoguchi, T; Inuo, M; Kobayashi, K; Matsumoto, S; Nawata, H; Sonoda, N; Sonta, T; Tsubouchi, H; Utsumi, H; Yasukawa, K1
Akhtar, S; Benboubetra, M; Benter, IF; Griffiths, SM; Yousif, MH1
Dong, J; Liu, X; Lv, Y; Niu, X1
Chen, KY; Chuang, M; Hunt, D; Kargacin, G; Severson, DL; Shimoni, Y1
Blázovics, A; Rosta, K; Ruzicska, E; Somogyi, A; Tóth, M; Vér, A1
Ahn, KO; Choi, YH; Chung, BH; Ito, S; Kim, J; Li, C; Lim, SW; Sugawara, A; Sun, BK; Yang, CW; Yang, JH; Yoon, KH1
MacLeod, KM; McNeill, JH; Nagareddy, PR; Xia, Z1
Hashimoto, Y; Kon, Y; Konno, A; Tamura, J1
Claverie, F; Flores, C; García, J; León, C; Milena, FJ; Mora, C; Navarro, JF1
Chen, L; Huang, HQ; Liu, BC; Liu, DG; Liu, H; Ma, KL; Sun, J; Zhang, XL1
Bai, A; Bianchi, R; Cuccovillo, I; De Angelis, N; Doni, M; Fiordaliso, F; Ghezzi, P; Latini, R; Masson, S; Salio, M1
Banes-Berceli, AK; Brands, M; Caldwell, RW; Eaton, DC; Fulton, D; Ma, G; Marrero, MB; Shaw, S; Stern, DM1
Leng, SH; Lu, FE; Wang, KF; Xiao, YL; Xu, LJ1
Hayashi, Y; Kamata, K; Kobayashi, T; Matsumoto, T; Taguchi, K2
Brezniceanu, ML; Chan, JS; Chen, R; Fantus, IG; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Liu, F; Whiteside, CI; Zhang, SL1
H S, AK; Patel, RJ; Saini, AK; Sharma, SS1
Cao, W; Knapp, RR; Lau, K; Ma, JX; Mott, R; Wang, JJ; Zhang, SX1
Hayashi, M; Ichihara, A; Inagami, T; Kaneshiro, Y; Nabi, AH; Nakagawa, T; Nishiyama, A; Sakoda, M; Sugaya, T; Suzuki, F; Takemitsu, T1
Chen, YJ; Li, J; Quilley, J1
Abe, H; Arai, H; Doi, T; Fukatsu, A; Iehara, N; Kanamori, H; Kita, T; Matsubara, T; Mima, A; Nagai, K; Sumi, E; Takahashi, T1
Alvarez, MJ; Arribas, I; Bosch, RJ; Esbrit, P; Guitiérrez-Tarrés, MA; Izquierdo, A; López-Luna, P; Ortega, A; Romero, M1
Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM1
Danser, AH; Krop, M; van Esch, JH1
Achike, FI; Chin, LC; Mustafa, MR1
Bell, TD; Brands, MW; Fleming, C; Janardhanan, R; Rojas, M; Springfield, V; Sturgis, LC1
Jansson, L; Lai, EY; Patzak, A; Persson, AE1
Cai, H; Oak, JH1
Chen, LH; Ding, HL; Fu, ZZ; Wu, W1
Kashihara, N; Maeshima, Y; Makino, H; Maruyama, K; Okamoto, K; Okazaki, Y; Satoh, M; Sugaya, T; Sugiyama, H; Uchida, HA; Yamasaki, Y1
Casarini, DE; Irigoyen, MC; Ronchi, FA1
Banes-Berceli, AK; Ketsawatsomkron, P; Marrero, MB; Ogbi, S; Patel, B; Pollock, DM1
Batlle, D; Kanwar, Y; Lloveras, J; Soler, MJ; Wysocki, J; Ye, M1
Belmadani, S; Berecek, KH; Bernal, J; Dell'italia, L; Murphy-Ullrich, JE; Pallero, MA; Wei, CC1
Benter, IF; Kehinde, EO; Yousif, MH1
Chen, P; Edwards, PA; Guo, AM; Scicli, AG; Trick, G1
Ding, M; Graham, S; Ma, JX; Ma, R; Sours-Brothers, S; Yorio, T1
Abrahamian, R; Bikhazi, AB; Bitar, KM; Der-Boghossian, AH; Issa, NG; Kadi, LN; Maharsy, WM1
Gao, L; Kern, TS; Xi, X; Zhang, JZ1
Hussain, T; Siddiqui, AH1
Anderson, S; Komers, R; Lindsley, JN; Oyama, TT; Schutzer, W; Xue, H1
Lai, EY; Nordquist, L; Patzak, A; Persson, AE; Sjöquist, M1
Arrick, DM; Mayhan, WG; Sharpe, GM; Sun, H1
Kang, JJ; Meer, EJ; Peti-Peterdi, J; Sipos, A; Toma, I; Vargas, SL1
Chen, K; Emmett, T; Kargacin, G; Shimoni, Y1
Belmadani, S; Boulares, HA; Matrougui, K; Palen, DI; Zerfaoui, M1
Imamura, Y; Ishida, S; Kurihara, T; Nagai, N; Noda, K; Oike, Y; Okano, H; Ozawa, Y; Shinoda, K; Tsubota, K1
Hayashi, M; Kitajima, W; Saruta, T1
Ladenheim, EE; Murnane, JM; Ritter, S1
Ballermann, BJ; Brenner, BM; Skorecki, KL1
Atkinson, J; Boillat, N; Kohler, L; Lüthi, P; Peters-Haefeli, L1
Altura, BM; Lum, G; Turlapaty, PD1
Antonipillai, I; Horton, R; Jost-Vu, E; Nadler, J; Natarajan, R1
Abe, K; Fu, LP; Kanazawa, M; Kohzuki, M; Obara, K; Saito, T; Yasujima, M; Yoshida, K1
Patel, KP; Zhang, PL1
Blantz, RC; Vallon, V; Wead, LM1
Dai, S; Lee, S; McNeill, JH; Todd, ME1
Griffin, CA; Schambelan, M; Sechi, LA1
Mento, PF; Vernace, MA; Wilkes, BM1
Harker, CT; Kasiske, BL; Katz, SA; Keane, WF; O'Donnell, MP1
Flood, JF; Morley, JE1
Cameron, NE; Cotter, MA; Dines, KC; Maxfield, EK1
Charlesworth, JA; Duggan, K; Macdonald, GJ; Makarious, M1
House, F; Lidbury, P; Stevens, EJ; Tomlinson, DR; Willars, GB1
Jeremy, JY; Mikhailidis, DP; Thompson, CS1
Moura, RS; Santos, SF; Vieira, LM1
Heidland, A; Ling, H; Paczek, L; Vamvakas, S1
Assad, N; Stahl, RA; Thaiss, F; Wolf, G; Zahner, G1
Beenen, OH; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA2
Fleming, JT; Inman, SR; Porter, JP2
Banks, RO; Mathis, KM1
Bensaoula, T; Eichberg, J; Ottlecz, A; Peterson, RG1
Alder, VA; Cringle, SJ; Su, EN; Yu, DY; Yu, PK1
Anderson, S; Kennefick, TM; Oyama, TT; Thompson, MM; Vora, JP1
Epstein, M; Forster, HG; Hohman, TC; ter Wee, PM1
de Nucci, G; Fujihara, CK; Mattar, AL; Ribeiro, MO; Zatz, R1
Farina, NK; Hodgson, WC; Widdop, RE1
Hoeschen, RJ; Khatter, JC; Sadri, P; Zhang, M1
Allen, TJ; Casley, D; Cooper, ME; Jerums, G; Waldron, MJ1
Capers, Q; de Leon, H; Fukui, T; Griendling, KK; Harrison, DG; Ishizaka, N; Laursen, JB; Rajagopalan, S; Taylor, WR; Wilcox, JN1
Ferreira, AT; Hadad, SJ; Neri, R; Oshiro, ME; Schor, N1
Cazes, M; Cloarec, A; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E1
Dewhurst, M; Stevens, EJ; Tomlinson, DR1
Bertram, JF; Black, MJ; Briscoe, T; Jackson, B; Johnston, CI1
Cohen, A; Erlich, Y; Rosenmann, E; Rosenthal, T1
Akishita, M; Eto, M; Hashimoto, M; Kim, S; Kozaki, K; Nagano, K; Ouchi, Y; Sudo, N; Toba, K; Watanabe, M; Yoo, HJ; Yoshizumi, M1
Bartoli, E; Griffin, CA; Schambelan, M; Sechi, LA; Valentin, JP; Zingaro, L1
Brown, L; Marchant, C; Sernia, C; Wall, D1
Allen, TJ; Cao, Z; Cooper, ME; Hulthen, UL; Youssef, S1
Anderson, S; Kennefick, TM1
Izumi, Y; Kanmatsuse, K; Nakayama, T; Soma, M1
Mayhan, WG1
Crijns, FR; Struijker Boudier, HA; Wolffenbuttel, BH1
Pehowich, DJ1
Kihara, M; Mitsui, MK; Mitsui, Y; Nakasaka, Y; Okuda, K; Schmelzer, JD; Takahashi, M1
Campbell, DJ; Cooper, ME; Kelly, DJ; Skinner, SL; Wilkinson-Berka, JL1
Kamata, K; Mizutani, K1
Carmines, PK; Fallet, RW; Schoonmaker, GC1
Anversa, P; Fiordaliso, F; Kajstura, J; Latini, R; Leri, A; Li, B; Sonnenblick, EH1
Burns, KD; Imig, JD; Kumar, D; Levine, DZ; Navar, LG; Wehbi, G; Zimpelmann, J1
Cooper, ME; Cox, AJ; Gilbert, RE; Hendrich, EC; Jerums, G; Kelly, DJ; Lee, V; Osicka, T; Panagiotopoulos, S; Rumble, JR; Wilkinson-Berka, JL1
Schuitheiss, HP; Tschöpe, C; Walther, T1
Bessard, G; Caron, F; Devillier, P; Faure, P; Hakim, A; Halimi, S; Hardy, G; Morel, S; Peoc'h, M; Stanke-Labesque, F1
Shimoni, Y1
Boner, G; Erman, A; Giler, S; van Dijk, DJ1
Brands, MW; Fitzgerald, SM1
Kokot, F1
Christlieb, AR; Long, R1
Christlieb, AR3
Antonipillai, I; Horton, R; Jost-Vu, E1
Hurst, RD; Thompson, JC; Whiteside, CI1
Templeton, DM; Whiteside, C1
Bushfield, M; Griffiths, SL; Houslay, MD; Knowler, JT; Milligan, G; Mollner, S; Murphy, GJ; Parker, PJ; Pyne, NJ1
Awazu, M; Harvie, BR; Ichikawa, I; Kon, V; Parker, RE1
Fujishima, M; Iwase, M; Nakao, Y; Sadoshima, S; Takata, Y; Takishita, S; Tomita, Y; Tsuchihashi, T; Yamashita, Y1
Gottardo, G; Malendowicz, LK; Mazzocchi, G; Nussdorfer, GG; Rebuffat, P1
Andreis, PG; Cavallini, L; Mazzocchi, G; Nussdorfer, GG; Rebuffat, P1
Aurell, M; Björck, S1
Gillham, MJ; Sharp, PA; Thomas, JH1
Blackmore, PF; Exton, JH; Johnson, EH; Krone, PK; Lynch, CJ; Wange, RL1
McGiff, JC; Quilley, J; Sarubbi, D1
Hill, MA; Larkins, RG1
Qiu, CL; Zhou, J1
Belloni, AS; Gottardo, G; Malendowicz, LK; Mazzocchi, G; Nussdorfer, GG; Rebuffat, P1
Mendelsohn, FA1
Azukizawa, S; Imaizumi, N; Kigoshi, T; Konishi, F; Morimoto, S; Uchida, K; Yamamoto, I1
Barnett, R; Ko, YH; Scharschmidt, L; Schlondorff, D1
Ramos, OL1
Aynedjian, HS; Bank, N; Lahorra, G; Wilkes, BM1
Bennett, T; Gardiner, SM; Hebden, RA1
Brenner, BM; Zatz, R1
Fujiwara, Y; Haneda, M; Kikkawa, R; Kitamura, E; Shigeta, Y1
Wilkes, BM1
Head, RJ; Longhurst, PA; Panek, RL; Stitzel, RE1
Dunham, EW; Ha, H1
Arimura, T; Fujiwara, Y; Haneda, M; Kikkawa, R; Kitamura, E; Shigeta, Y1
Brezenoff, HE; Caputi, AP; Costa, G; Lupica, S; Magri, V; Squadrito, F; Trimarchi, GR1

Reviews

13 review(s) available for angiotensin ii and Alloxan Diabetes

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
[Behavioral and Molecular Pharmacological Study of the Role of Angiotensin II in Spinal Pain Transmission].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Volume: 138, Issue:10

    Topics: Angiotensin II; Animals; Brain; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Neuralgia; p38 Mitogen-Activated Protein Kinases; Pain; Pain Perception; Peptidyl-Dipeptidase A; Phosphorylation; Spinal Cord; Synaptic Transmission; Up-Regulation

2018
[The cortical collecting duct plays a pivotal role in the kidney's local renin-angiotensin system].
    Orvosi hetilap, 2013, Apr-28, Volume: 154, Issue:17

    Topics: Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Female; Fetus; Humans; Hypertension; Juxtaglomerular Apparatus; Kidney Tubules, Collecting; Pregnancy; Pregnancy Complications, Cardiovascular; Renin; Renin-Angiotensin System

2013
The novel roles of glucagon-like peptide-1, angiotensin II, and vitamin D in islet function.
    Advances in experimental medicine and biology, 2010, Volume: 654

    Topics: Angiotensin II; Angiotensins; Animals; Blood Pressure; Cell Nucleus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Humans; Islets of Langerhans; Mice; Models, Biological; Peptides; Vitamin D

2010
Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model.
    Experimental diabetes research, 2011, Volume: 2011

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Mice; Models, Neurological; Nerve Degeneration; Oxidative Stress; Rats; Reactive Oxygen Species; Renin-Angiotensin System; Retinal Degeneration; Signal Transduction

2011
Impaired proteolytic activity as a potential cause of progressive renal disease.
    Mineral and electrolyte metabolism, 1996, Volume: 22, Issue:1-3

    Topics: Acidosis; Ammonia; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Dietary Proteins; Endopeptidases; Glomerulonephritis; Humans; Hypertrophy; Inflammation; Insulin-Like Growth Factor I; Kidney; Kidney Diseases; Proteins; Transforming Growth Factor beta

1996
Role of angiotensin II in diabetic nephropathy.
    Seminars in nephrology, 1997, Volume: 17, Issue:5

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Enalapril; Hemodynamics; Plasma Volume; Rats; Renin-Angiotensin System

1997
[The renin-angiotensin-aldosterone system in diabetics].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1978, Jul-31, Volume: 33, Issue:31

    Topics: Aldosterone; Angiotensin II; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Hypertension; Kidney; Renin

1978
Diabetes mellitus, the renin-angiotensin system, and angiotensin-converting enzyme inhibition.
    Nephron, 1990, Volume: 55 Suppl 1

    Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Humans; Hypertension; Kidney; Rats; Receptors, Angiotensin; Renin; Sodium

1990
[Renal angiotensin II receptors and their alteration in renal diseases].
    Sheng li ke xue jin zhan [Progress in physiology], 1989, Volume: 20, Issue:3

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Glomerulonephritis; Humans; Kidney; Receptors, Angiotensin

1989
Localization and properties of angiotensin receptors.
    Journal of hypertension, 1985, Volume: 3, Issue:4

    Topics: Adrenal Glands; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Platelets; Brain; Cell Membrane; Cell Nucleus; Cells, Cultured; Diabetes Mellitus, Experimental; Guanine Nucleotides; Heart; Humans; Hypothalamus; Insulin; Kidney; Kidney Glomerulus; Kidney Tubules; Liver; Macrophages; Mineralocorticoids; Molecular Weight; Monocytes; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Myocardium; Pituitary Gland; Pituitary Hormones; Receptors, Angiotensin; Receptors, Cell Surface; Renin; Sodium; Tissue Distribution

1985
Pathogenesis of diabetic microangiopathy. The hemodynamic view.
    The American journal of medicine, 1986, Volume: 80, Issue:3

    Topics: Angiotensin II; Animals; Basement Membrane; Blood Pressure; Capillaries; Capillary Permeability; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hemodynamics; Humans; Hypertension; Hypoxia; Kidney Glomerulus; Microcirculation; Prostaglandins; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Retinal Vessels; Vasodilation

1986
Diabetes and hypertensive vascular disease. Mechanisms and treatment.
    The American journal of cardiology, 1973, Sep-20, Volume: 32, Issue:4

    Topics: Alloxan; Angiotensin II; Animals; Blood Volume; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Hypertension; Hypertension, Renal; Juxtaglomerular Apparatus; Nephrosclerosis; Rats; Renin; Sympathetic Nervous System

1973

Trials

2 trial(s) available for angiotensin ii and Alloxan Diabetes

ArticleYear
    The Lancet. Microbe, 2022, Volume: 3, Issue:2

    Topics: Acoustics; Adsorption; Angiotensin II; Animals; Anti-Bacterial Agents; Azithromycin; Calcium; Carbon; Charcoal; Child; Chlorides; Copper; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Resistance, Bacterial; Ecosystem; Epigenesis, Genetic; Female; Fibroblasts; Fibrosis; Gallium Radioisotopes; Heterozygote; Hot Temperature; Humans; Hydrogen-Ion Concentration; Inflammasomes; Inflammation; Kinetics; Macrolides; Magnetic Resonance Imaging; Malawi; Male; Mass Drug Administration; Methylene Blue; Mice; Neuroendocrine Tumors; NLR Family, Pyrin Domain-Containing 3 Protein; Octreotide; Organometallic Compounds; Oxidative Stress; Phenotype; Positron-Emission Tomography; Prevalence; Prognosis; Rats; Receptors, Somatostatin; Retrospective Studies; Rivers; Streptococcus pneumoniae; Trachoma; Water Pollutants, Chemical; Zinc Compounds

2022
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021

Other Studies

308 other study(ies) available for angiotensin ii and Alloxan Diabetes

ArticleYear
Angiotensin IV attenuates diabetic cardiomyopathy
    Theranostics, 2021, Volume: 11, Issue:18

    Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Forkhead Box Protein O1; Glucose; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Quinolones; Signal Transduction; Streptozocin; Ventricular Dysfunction, Left

2021
Deficiency of the kidney tubular angiotensin II type1 receptor-associated protein ATRAP exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarization.
    Kidney international, 2022, Volume: 101, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Humans; Kidney; Macrophages; Male; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Streptozocin

2022
Lay A TRAP for myeloid cell response in diabetic kidney disease.
    Kidney international, 2022, Volume: 101, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Mice; Myeloid Cells; Receptor, Angiotensin, Type 1

2022
Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis.
    Acta pharmacologica Sinica, 2022, Volume: 43, Issue:10

    Topics: Angiotensin II; Animals; Antiviral Agents; Apoptosis; Diabetes Mellitus, Experimental; Heart Failure; Membrane Proteins; Mice; Mice, Knockout; Mice, Transgenic; Mitochondrial Proteins; Myocytes, Cardiac; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Rats; Stroke Volume; Ubiquitin-Protein Ligases; Ventricular Function, Left

2022
Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes.
    British journal of pharmacology, 2023, Volume: 180, Issue:1

    Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Humans; Hypertension; Kidney Diseases; Liver; Rats; Renin; Renin-Angiotensin System; RNA, Small Interfering; Valsartan

2023
Histomorphometry Changes and Decreased Reactivity to Angiotensin II in the Ileum and Colon of Streptozotocin-Induced Diabetic Rats.
    International journal of molecular sciences, 2022, Oct-31, Volume: 23, Issue:21

    Topics: Angiotensin II; Animals; Colon; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Ileum; Male; Rats; Rats, Wistar; Streptozocin

2022
Effectiveness of Hydroalcoholic Seed Extract of
    Oxidative medicine and cellular longevity, 2023, Volume: 2023

    Topics: Angiotensin II; Animals; Cytokines; Diabetes Mellitus, Experimental; Male; Models, Animal; Pancreas; Plant Extracts; Rats; Rats, Wistar; Renin-Angiotensin System; Securidaca; Seeds; Streptozocin

2023
Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro.
    Pharmacological reports : PR, 2019, Volume: 71, Issue:6

    Topics: AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Aorta; Arthritis, Rheumatoid; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Endothelium, Vascular; Female; Glucosides; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Kinases; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred WF; Receptors, Purinergic P2Y12; Selective Estrogen Receptor Modulators; Sodium-Glucose Transporter 2 Inhibitors; Tamoxifen; Ticagrelor; Vascular Cell Adhesion Molecule-1; Vasodilation

2019
A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage.
    Prostaglandins & other lipid mediators, 2020, Volume: 148

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Epoxide Hydrolases; Mice; Mice, Inbred C57BL; Mice, Knockout; Microvessels; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Retina

2020
Effect of
    Archives of physiology and biochemistry, 2022, Volume: 128, Issue:6

    Topics: Acacia; Angiotensin II; Animals; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin-1; Glucose; Glycated Hemoglobin; Gum Arabic; Insulins; Kidney; Male; Rats; Rats, Sprague-Dawley; Senegal; Transforming Growth Factor beta1

2022
Angiotensin II Induces Increased Myocardial Expression of Receptor for Advanced Glycation End Products, Monocyte/Macrophage Infiltration and Circulating Endothelin-1 in Rats With Experimental Diabetes.
    Canadian journal of diabetes, 2020, Volume: 44, Issue:7

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Endothelin-1; Glycation End Products, Advanced; Macrophages; Male; Monocytes; Myocardium; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Vasoconstrictor Agents

2020
Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.
    Environmental toxicology and pharmacology, 2020, Volume: 80

    Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diminazene; Imidazoles; Ischemia; Kidney; Liver; Male; Myocardium; Oxidative Stress; Peptide Fragments; Peroxidase; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes

2020
Angiotensin IV improves spatial memory in streptozotocin‑induced diabetic rats by reducing oxidative stress and altering BDNF levels.
    Acta neurobiologiae experimentalis, 2021, Volume: 81, Issue:2

    Topics: Angiotensin II; Animals; Brain-Derived Neurotrophic Factor; Cognition; Diabetes Mellitus, Experimental; Hippocampus; Male; Maze Learning; Oxidative Stress; Rats, Wistar; Spatial Memory; Streptozocin; Superoxide Dismutase

2021
Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression.
    Molecular biology reports, 2021, Volume: 48, Issue:9

    Topics: Angiopoietin-Like Protein 2; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Kidney; Male; NF-kappa B; Protective Agents; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; RNA, Messenger; Streptozocin; Toll-Like Receptor 4; Treatment Outcome; Valsartan

2021
[Irbesartan ameliorates cardiac inflammation in type 2 diabetic db/db mice].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2016, Apr-20, Volume: 37, Issue:4

    Topics: Actins; Angiotensin II; Animals; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Interleukin-6; Irbesartan; Mice; Obesity; Random Allocation; Real-Time Polymerase Chain Reaction; Signal Transduction; Tetrazoles; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2016
Rho-kinase and the nitric oxide pathway modulate basilar arterial reactivity to acetylcholine and angiotensin II in streptozotocin-induced diabetic mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:9

    Topics: Acetylcholine; Amides; Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; rho-Associated Kinases; Streptozocin; Time Factors

2017
Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.
    Physiological genomics, 2017, Oct-01, Volume: 49, Issue:10

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterial Pressure; Arterioles; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Losartan; Male; Mice, Inbred BALB C; Perfusion; Receptor, Angiotensin, Type 1; Vasoconstriction

2017
MicroRNA-145 regulates disabled-2 and Wnt3a expression in cardiomyocytes under hyperglycaemia.
    European journal of clinical investigation, 2018, Volume: 48, Issue:1

    Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Apoptosis; beta Catenin; Blood Glucose; Diabetes Mellitus, Experimental; Heart Ventricles; Hyperglycemia; Male; MicroRNAs; Myocardium; Myocytes, Cardiac; Rats, Wistar; Wnt3 Protein

2018
Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells.
    DNA and cell biology, 2018, Volume: 37, Issue:2

    Topics: Alprostadil; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Endothelin-1; Epithelial Cells; Kidney Tubules; Macrophages; Male; Nephritis, Interstitial; Rats, Wistar

2018
Diabetes Reduces Severity of Aortic Aneurysms Depending on the Presence of Cell Division Autoantigen 1 (CDA1).
    Diabetes, 2018, Volume: 67, Issue:4

    Topics: Adult; Aged; Angiotensin II; Animals; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Aortic Rupture; Autoantigens; Collagen; Diabetes Mellitus, Experimental; Female; Gene Expression Regulation; Humans; Macrophages; Male; Matrix Metalloproteinase 12; Mice; Mice, Knockout; Mice, Knockout, ApoE; Middle Aged; Severity of Illness Index; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Vasoconstrictor Agents

2018
Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.
    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2018, Volume: 43, Issue:6

    Topics: Angiotensin II; Animals; Biomarkers; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme Inhibitors; Islets of Langerhans; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

2018
Angiotensin II Silencing Alleviates Erectile Dysfunction Through Down-Regulating the Rhoa/Rho Kinase Signaling Pathway in Rats with Diabetes Mellitus.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 45, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Down-Regulation; Erectile Dysfunction; Male; Penis; Radioimmunoassay; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction

2018
Effects of microRNA-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin II- extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy.
    Acta ophthalmologica, 2018, Volume: 96, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Flow Cytometry; Gene Expression Regulation; Immunohistochemistry; Male; MAP Kinase Signaling System; MicroRNAs; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA; Signal Transduction

2018
Effect of pioglitazone on vasopressor responses to adrenergic agonists and angiotensin II in diabetic and non-diabetic spontaneously hypertensive rats.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:3

    Topics: Adrenergic Agonists; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hemodynamics; Hypertension; Hypoglycemic Agents; Pioglitazone; Rats; Rats, Inbred SHR; Vasoconstrictor Agents

2018
Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy.
    Laboratory investigation; a journal of technical methods and pathology, 2018, Volume: 98, Issue:9

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Feedback, Physiological; Female; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Sex Characteristics

2018
ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice.
    Clinics (Sao Paulo, Brazil), 2018, 08-02, Volume: 73

    Topics: Angiotensin II; Animals; Autonomic Nervous System; Blood Glucose; Cardiovascular System; Diabetes Mellitus, Experimental; Gene Dosage; Heart Rate; Immunohistochemistry; Kidney; Male; Mice; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Random Allocation; Vagus Nerve

2018
The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.
    Journal of the American Society of Nephrology : JASN, 2018, Volume: 29, Issue:10

    Topics: Amino Acid Substitution; Angiotensin II; Animals; Catalytic Domain; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Sodium Channels; Inflammation; Interleukin-1beta; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; Natriuresis; Oligopeptides; Peptidyl-Dipeptidase A; Protein Domains; Renin-Angiotensin System

2018
Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
    European journal of pain (London, England), 2019, Volume: 23, Issue:4

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperesthesia; Male; Mice; Neuralgia; p38 Mitogen-Activated Protein Kinases; Pain Perception; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Spinal Cord; Vasodilator Agents

2019
[Aliskiren inhibits angiotensin II/angiotensin 1-7(Ang II/Ang1-7) signal pathway in rats with diabetic nephropathy].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2018, Volume: 34, Issue:10

    Topics: Amides; Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fumarates; Male; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction

2018
Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
    Molecular medicine reports, 2019, Volume: 19, Issue:3

    Topics: Albuminuria; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Glucose; Humans; Kidney Glomerulus; NFATC Transcription Factors; Podocytes; Rats; TRPC6 Cation Channel

2019
The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    International journal of molecular sciences, 2019, May-16, Volume: 20, Issue:10

    Topics: Angiotensin II; Animals; Blood Glucose; Caloric Restriction; Carbazoles; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Heme Oxygenase-1; Male; Malondialdehyde; Mesoporphyrins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Obesity; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protoporphyrins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sirtuin 1

2019
Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease.
    Scientific reports, 2019, 05-22, Volume: 9, Issue:1

    Topics: Acetylcysteine; Actin Cytoskeleton; Angiotensin II; Animals; Calcium; Cell Adhesion; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Humans; Losartan; Mice; Mice, Inbred C57BL; Microfilament Proteins; Molecular Motor Proteins; Myosin Heavy Chains; NADPH Oxidase 4; Podocytes; Rats; Rats, Inbred Strains; Reactive Oxygen Species; Receptors, Leptin; RNA Interference; TRPC6 Cation Channel

2019
Diabetes confers a vasoprotective role to the neurocompensatory response elicited by carotid balloon injury: consequences on contralateral carotid tone and blood flow.
    European journal of pharmacology, 2013, May-15, Volume: 708, Issue:1-3

    Topics: Angioplasty, Balloon; Angiotensin II; Animals; Aorta; Carotid Artery Injuries; Cerebrovascular Circulation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hydrogen Peroxide; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Superoxides; Vasoconstriction

2013
Role of angiotensin II and angiotensin-(1-7) in diabetes-induced oxidative DNA damage in the corpus cavernosum.
    Fertility and sterility, 2013, Volume: 100, Issue:1

    Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; DNA Damage; Male; Oxidative Stress; Penis; Peptide Fragments; Proto-Oncogene Mas; Random Allocation; Rats; Rats, Wistar; Signal Transduction

2013
Ang(1-7) treatment attenuates β-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes.
    Journal of endocrinological investigation, 2013, Volume: 36, Issue:11

    Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Insulin; Insulin Secretion; Islets of Langerhans; Male; Microcirculation; Nitric Oxide; Nitric Oxide Synthase Type III; Pancreas; Peptide Fragments; Rats; Rats, Wistar

2013
The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endorphins; Epithelial Cells; Glucagon; Glutathione Peroxidase; Hydrogen Peroxide; Insulin; Isoenzymes; Kidney; Losartan; Male; Malondialdehyde; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Superoxide Dismutase

2013
[Effects of shenqi compound on the mRNA expression of AT1R in the aorta of GK rats].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2013, Volume: 33, Issue:3

    Topics: Angiotensin II; Animals; Aorta; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Male; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Triglycerides

2013
Effect of catalpol on diabetic nephropathy in rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Aug-15, Volume: 20, Issue:11

    Topics: Angiotensin II; Animals; Collagen Type IV; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Fibronectins; Iridoid Glucosides; Kidney; Male; Organ Size; Phytotherapy; Random Allocation; Rats; Rats, Sprague-Dawley; Rehmannia; RNA, Messenger; Transforming Growth Factor beta1

2013
Regulation of urinary ACE2 in diabetic mice.
    American journal of physiology. Renal physiology, 2013, Aug-15, Volume: 305, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A

2013
Beneficial effects of β-conglycinin on renal function and nephrin expression in early streptozotocin-induced diabetic nephropathy rats.
    The British journal of nutrition, 2014, Jan-14, Volume: 111, Issue:1

    Topics: Angiotensin II; Animals; Antigens, Plant; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Proteins; Globulins; Glycation End Products, Advanced; Glycine max; Insulin Resistance; Isoflavones; Kidney; Male; Membrane Proteins; Peptidyl-Dipeptidase A; Phytotherapy; Plant Preparations; Rats; Rats, Inbred SHR; Seed Storage Proteins; Soybean Proteins; Thiobarbituric Acid Reactive Substances; Triglycerides

2014
Centrally mediated erectile dysfunction in rats with type 1 diabetes: role of angiotensin II and superoxide.
    The journal of sexual medicine, 2013, Volume: 10, Issue:9

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Behavior, Animal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Erectile Dysfunction; Excitatory Amino Acid Agonists; Humans; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Paraventricular Hypothalamic Nucleus; Penile Erection; Penis; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Superoxides

2013
Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.
    Journal of bone and mineral metabolism, 2014, Volume: 32, Issue:3

    Topics: Acid Phosphatase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Isoenzymes; Male; Mice; Mice, Inbred DBA; NF-kappa B; Osteocalcin; Osteoclasts; Random Allocation; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin; Tartrate-Resistant Acid Phosphatase; Tibia; Transforming Growth Factor beta; Up-Regulation

2014
[Changes of angiotensin converting enzyme 2 in the occurrence and development of diabetic renal injury in rat].
    Sheng li xue bao : [Acta physiologica Sinica], 2013, Aug-25, Volume: 65, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley

2013
Yeast exposure in the preparation of steamed rehmannia root improving its effects on alloxan-induced diabetic rats.
    Journal of ethnopharmacology, 2013, Nov-25, Volume: 150, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Aldosterone; Alloxan; Angiotensin II; Animals; Behavior, Animal; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fermentation; Male; Plant Extracts; Plant Roots; Potassium; Rats; Rats, Wistar; Rehmannia; Sodium; Steam; Thromboxane B2; Yeast, Dried

2013
PTGER1 deletion attenuates renal injury in diabetic mouse models.
    The American journal of pathology, 2013, Volume: 183, Issue:6

    Topics: Actins; Angiotensin II; Animals; Bridged Bicyclo Compounds; Caproates; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Gene Deletion; Gene Expression Regulation; Glomerular Filtration Barrier; Mesenteric Arteries; Mice; Mice, Knockout; Receptors, Prostaglandin E, EP1 Subtype; Renin-Angiotensin System; Superoxides; Vasoconstriction

2013
Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
    Cardiovascular diabetology, 2013, Nov-12, Volume: 12

    Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Down-Regulation; Fumarates; Kallikreins; Kininogens; Kinins; Mice; Mice, Knockout; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Ultrasonography; Valine; Valsartan

2013
Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 63

    Topics: Angiotensin II; Animals; Apoptosis; Caspases; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Enzyme-Linked Immunosorbent Assay; In Situ Nick-End Labeling; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Quercetin; Rats; Reactive Oxygen Species; Streptozocin

2014
Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:2

    Topics: Angiotensin II; Animals; Benzylidene Compounds; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Renin-Angiotensin System; Signal Transduction; Streptozocin

2014
Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice.
    Cardiovascular diabetology, 2014, Feb-10, Volume: 13

    Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Male; Mice; Mice, Knockout; Organ Culture Techniques; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Treatment Outcome; Vasodilation

2014
Heterogeneous downregulation of angiotensin II AT1-A and AT1-B receptors in arterioles in STZ-induced diabetic rat kidneys.
    BioMed research international, 2014, Volume: 2014

    Topics: Angiotensin II; Animals; Arterioles; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Kidney; Myocytes, Smooth Muscle; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin

2014
Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    The American journal of pathology, 2014, Volume: 184, Issue:6

    Topics: Angiotensin II; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Glucose; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Podocytes; Rats; Rats, Wistar; Renin-Angiotensin System; TRPC Cation Channels; TRPC6 Cation Channel

2014
Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Acute Kidney Injury; Angiogenesis Inhibitors; Angiotensin II; Animals; Cell Line; Diabetes Mellitus, Experimental; Endostatins; Heterocyclic Compounds, 3-Ring; Male; Membrane Proteins; Mice; Phosphorylation; Podocytes; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Streptozocin; Vascular Endothelial Growth Factor A

2014
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.
    Kidney international, 2015, Volume: 87, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Male; Mesangial Cells; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Valsartan; Vascular Endothelial Growth Factor A

2015
[Protective effects and mechanism of congguiyishen capsules on diabetic nephropathy rats].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2014, Volume: 37, Issue:5

    Topics: Angiotensin II; Animals; Blood Glucose; Capsules; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Female; Hypoglycemic Agents; Kidney; Male; Plants, Medicinal; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin

2014
Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway.
    Chemico-biological interactions, 2015, Feb-05, Volume: 227

    Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Collagen; Diabetes Mellitus, Experimental; Fibroblasts; Glucose; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Smad3 Protein; Stilbenes; Transforming Growth Factor beta1; Up-Regulation

2015
Experimental gestational diabetes mellitus induces blunted vasoconstriction and functional changes in the rat aorta.
    BioMed research international, 2014, Volume: 2014

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetes, Gestational; Female; Humans; Losartan; Phenylephrine; Pregnancy; Rats; Vasoconstriction; Vasoconstrictor Agents; Vasodilation

2014
The effects of Ins2(Akita) diabetes and chronic angiotensin II infusion on cystometric properties in mice.
    Neurourology and urodynamics, 2015, Volume: 34, Issue:1

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Male; Mice; Urinary Bladder; Urinary Bladder Diseases; Urination

2015
Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
    Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:12

    Topics: Albuminuria; Angiotensin II; Animals; Cell Dedifferentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Knockout Techniques; Glomerular Basement Membrane; Glucose; Humans; LIM-Homeodomain Proteins; Male; Mice; Muscle Proteins; Podocytes; Protein Transport; Transcription Factors; Transforming Growth Factor beta1; Wnt Signaling Pathway

2015
Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia.
    Biochemical and biophysical research communications, 2015, May-29, Volume: 461, Issue:2

    Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Aorta; Blood Pressure; Diabetes Mellitus, Experimental; Hyperglycemia; Hyperinsulinism; Hypertension; Male; Peptidyl-Dipeptidase A; Rats, Wistar; Transforming Growth Factor beta; Umbelliferones

2015
The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.
    Vascular pharmacology, 2016, Volume: 76

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Blood Pressure; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypertension; Losartan; Male; Mice; Microvessels; Muscle, Smooth, Vascular; Pilot Projects; Receptor, Angiotensin, Type 1; Renin-Angiotensin System

2016
Angiotensin type 1 receptor mediates renal production and conversion of prostaglandins E2 to F2α in conscious diabetic rats.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2015, Volume: 16, Issue:4

    Topics: Angiotensin II; Animals; Consciousness; Diabetes Mellitus, Experimental; Dinoprost; Dinoprostone; Extracellular Fluid; Kidney; Male; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1

2015
Changes in protein and gene expression of angiotensin II receptors (AT1 and AT2) in aorta of diabetic and hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2016, Volume: 38, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Diabetes Mellitus, Experimental; Gene Expression Profiling; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger

2016
Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
    Journal of molecular medicine (Berlin, Germany), 2016, Volume: 94, Issue:2

    Topics: Angiotensin II; Animals; Biomarkers; Blood Chemical Analysis; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Fibrosis; Kidney Function Tests; Male; Peptide Fragments; Podocytes; Rats; Receptor, Angiotensin, Type 1; Renin; Signal Transduction; Smad3 Protein; Streptozocin; Transforming Growth Factor beta1; Vaccines

2016
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice.
    Endocrinology, 2015, Volume: 156, Issue:12

    Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Cell Membrane; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Progression; Insulin-Secreting Cells; Insulinoma; Islets of Langerhans; Male; Mice; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Rats; RNA, Messenger

2015
Up-regulation of the Ang II/AT1 receptor may compensate for the loss of gastric antrum ICC via the PI3k/Akt signaling pathway in STZ-induced diabetic mice.
    Molecular and cellular endocrinology, 2016, Mar-05, Volume: 423

    Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Gastric Mucosa; Interstitial Cells of Cajal; Male; Mice, Inbred ICR; Myocytes, Smooth Muscle; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyloric Antrum; Receptor, Angiotensin, Type 1; Signal Transduction; Streptozocin; Up-Regulation

2016
The bioflavonoid quercetin synergises with PPAR-γ agonist pioglitazone in reducing angiotensin-II contractile effect in fructose-streptozotocin induced diabetic rats.
    Biochimie, 2016, Volume: 125

    Topics: Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; Fructose; Male; Muscle Contraction; Pioglitazone; PPAR gamma; Quercetin; Rats; Rats, Sprague-Dawley; Thiazolidinediones

2016
Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
    Journal of nephrology, 2016, Volume: 29, Issue:6

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arachidonate 12-Lipoxygenase; Cadherins; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, High-Fat; Kidney Glomerulus; Lipoxygenase Inhibitors; Losartan; Male; Membrane Proteins; Mice; Podocytes; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Streptozocin

2016
Enhanced nitric oxide generation from nitric oxide synthases as the cause of increased peroxynitrite formation during acute restraint stress: Effects on carotid responsiveness to angiotensinergic stimuli in type-1 diabetic rats.
    European journal of pharmacology, 2016, Jul-15, Volume: 783

    Topics: Angiotensin II; Animals; Behavior, Animal; Carotid Arteries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelial Cells; Enzyme Activation; Gene Expression Regulation, Enzymologic; Male; Nitric Oxide; Nitric Oxide Synthase; Peroxynitrous Acid; Phenylephrine; Phosphorylation; Rats; Rats, Wistar; Restraint, Physical; Stress, Psychological; Vasoconstriction

2016
Long-Term Supplementation of Microencapsulated ursodeoxycholic Acid Prevents Hypertension in a Mouse Model of Insulin Resistance.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2017, Volume: 125, Issue:1

    Topics: Angiotensin II; Animals; Capsules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Hypertension; Insulin Resistance; Male; Mice; Time Factors; Ursodeoxycholic Acid

2017
[Effect of Danzhi Jiangtang Capsule on Myocardial Fibrosis in Diabetic Rats].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2015, Volume: 38, Issue:10

    Topics: Angiotensin II; Animals; Blood Glucose; Capsules; Collagen Type III; Diabetes Mellitus, Experimental; Down-Regulation; Drugs, Chinese Herbal; Fibrosis; Glucose; Injections, Intraperitoneal; Insulin; Matrix Metalloproteinase 2; Myocardium; Phosphorylation; Rats; Smad3 Protein; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta1; Up-Regulation

2015
The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, 01-01, Volume: 32, Issue:1

    Topics: Albumins; Angiotensin II; Angiotensinogen; Animals; Cell Membrane Permeability; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelial Cells; Glucose; Humans; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sweetening Agents

2017
[Protective effect and mechanism of β-CM7 on renin angiotensin system & diabetic cardiomyopathy].
    Sheng wu gong cheng xue bao = Chinese journal of biotechnology, 2016, Volume: 32, Issue:2

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Endorphins; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; RNA, Messenger

2016
Involvement of Spinal Angiotensin II System in Streptozotocin-Induced Diabetic Neuropathic Pain in Mice.
    Molecular pharmacology, 2016, Volume: 90, Issue:3

    Topics: Angiotensin II; Animals; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Hyperalgesia; Injections; Lumbar Vertebrae; Male; Mice; Neuralgia; p38 Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Phosphorylation; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Spinal Cord; Spinal Cord Dorsal Horn; Streptozocin; Time Factors; Touch

2016
Short-term administration of melatonin or ghrelin on diabetic rats: effects on angiotensin II and vasopressin-induced uterine contractility.
    Physiological research, 2017, 03-31, Volume: 66, Issue:1

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Drug Administration Schedule; Female; Ghrelin; Melatonin; Rats; Rats, Wistar; Treatment Outcome; Uterine Contraction; Vasopressins

2017
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
    Kidney international, 2017, Volume: 91, Issue:6

    Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Autoantigens; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Kidney; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Time Factors

2017
Expression and localization of the AT
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, alpha-1; Renin-Angiotensin System; Tunica Intima; Tunica Media

2017
Differential response of bone and kidney to ACEI in db/db mice: A potential effect of captopril on accelerating bone loss.
    Bone, 2017, Volume: 97

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone and Bones; Bone Resorption; Calcium; Captopril; Diabetes Mellitus, Experimental; Femur; Fibrosis; Kidney; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Renin-Angiotensin System; RNA, Messenger; Tibia; Vitamin D3 24-Hydroxylase; X-Ray Microtomography

2017
Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2008, Volume: 9, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Immunohistochemistry; Irbesartan; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2008
Involvement of AT(1) angiotensin receptors in the vasomodulatory effect of des-aspartate-angiotensin I in the rat renal vasculature.
    Peptides, 2008, Volume: 29, Issue:10

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Kidney; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1

2008
Enalapril treatment restores the decreased proximal tubule reabsorption in response to acute volume expansion in diabetic rats.
    Life sciences, 2008, Aug-29, Volume: 83, Issue:9-10

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blood Volume; Diabetes Mellitus, Experimental; Enalapril; Glomerular Filtration Rate; Hydrostatic Pressure; Kidney Tubules, Proximal; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System

2008
Renal ACE and ACE2 expression in early diabetic rats.
    Nephron. Experimental nephrology, 2008, Volume: 110, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Immunohistochemistry; Kidney Cortex; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger

2008
Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Journal of the American College of Cardiology, 2008, Aug-19, Volume: 52, Issue:8

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Fibrosis; Hypertrophy; Metallothionein; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; NADP; Oxidative Stress; Ventricular Remodeling

2008
Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 295, Issue:5

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypoglycemic Agents; Imidazoles; In Vitro Techniques; Insulin; Kidney; Male; Microdialysis; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Valine; Valsartan

2008
Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy?
    The Journal of physiology, 2008, Nov-15, Volume: 586, Issue:22

    Topics: Angiotensin II; Animals; Binding Sites; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Phosphorylation; Protein Subunits; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger; Sodium-Potassium-Exchanging ATPase

2008
High glucose increases the expression of Gq/11alpha and PLC-beta proteins and associated signaling in vascular smooth muscle cells.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:5

    Topics: Angiotensin II; Animals; Cell Line; Diabetes Mellitus, Experimental; Endothelin-1; Glucose; GTP-Binding Protein alpha Subunits, Gq-G11; Inositol 1,4,5-Trisphosphate; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phospholipase C beta; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Time Factors

2008
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.
    Diabetes, 2008, Volume: 57, Issue:12

    Topics: Amides; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Benzazepines; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Experimental; Endomyocardial Fibrosis; Fumarates; Insulin; Myocytes, Cardiac; Oxidative Stress; Rats; Renin; Tetrazoles

2008
Ameliorative effect of Captopril and Valsartan on an animal model of diabetic cardiomyopathy.
    Biological & pharmaceutical bulletin, 2008, Volume: 31, Issue:11

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Female; Isoenzymes; L-Lactate Dehydrogenase; Male; Microscopy, Electron; Myocardium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2008
[Effects of Tangxinping Capsule on angiotensin II and its type 1 receptor and myocardial ultrastructure in diabetic rats].
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2008, Volume: 6, Issue:11

    Topics: Angiotensin II; Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Male; Myocardium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger

2008
Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.
    British journal of pharmacology, 2008, Volume: 155, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelin A Receptor Antagonists; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Hypertension; Insulin; Losartan; Male; Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Receptor, Endothelin A; Streptozocin; Vasoconstriction

2008
Role of kidney ADP-ribosyl cyclase in diabetic nephropathy.
    American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:2

    Topics: ADP-ribosyl Cyclase; Albuminuria; Angiotensin II; Animals; Azo Compounds; Cell Nucleus; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix Proteins; Kidney; Male; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Phosphorylation; Proto-Oncogene Proteins c-akt

2009
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Retinal Barrier; Capillary Permeability; Cell Line; Dextrans; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Fluoresceins; Humans; Mice; Mice, Inbred C57BL; Perindopril; Retina; Tight Junctions; Vascular Endothelial Growth Factor A

2009
Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Hypertension; Kallikreins; Kinins; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Retinal Artery; Streptozocin; Tetrazoles

2009
Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.
    Pharmacological research, 2009, Volume: 59, Issue:4

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; NF-kappa B; Nuclear Proteins; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Signal Transduction

2009
Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy.
    Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:2

    Topics: Abietanes; Angiotensin II; Animals; Blood Glucose; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Immunohistochemistry; Kidney; Macrophages; Monocytes; Neutrophil Infiltration; Phenanthrenes; Protective Agents; Proteinuria; Rats; Transforming Growth Factor beta1

2009
Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis.
    Journal of pharmacological sciences, 2009, Volume: 109, Issue:2

    Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fibrosis; Heart Failure; Hyperglycemia; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Tetrazoles

2009
Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:4

    Topics: Angiotensin II; Animals; Aorta; Apolipoprotein A-I; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dimerization; Down-Regulation; Endothelium, Vascular; Gene Transfer Techniques; Humans; Hyperglycemia; Lipoproteins, HDL; Male; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction

2009
Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
    Autonomic & autacoid pharmacology, 2009, Volume: 29, Issue:1-2

    Topics: Amidines; Angiotensin II; Animals; Blood Glucose; Body Weight; Carbachol; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Histamine; Hydroxyeicosatetraenoic Acids; Kidney; Male; Mesenteric Arteries; Microsomes; Nitroprusside; Norepinephrine; Perfusion; Rats; Rats, Wistar; Renal Artery; Triazoles; Vasoconstriction; Vasodilation

2009
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:3

    Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ergocalciferols; Fibrosis; Glomerular Basement Membrane; Inflammation Mediators; Losartan; Macrophages; Mice; Mice, Inbred DBA; Podocytes; Renin; Renin-Angiotensin System; Time Factors; Vitamins

2009
Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats.
    Cardiovascular diabetology, 2009, Jun-22, Volume: 8

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Aorta, Thoracic; Biphenyl Compounds; Diabetes Mellitus, Experimental; In Vitro Techniques; Irbesartan; Losartan; Male; Rats; Rats, Wistar; rho-Associated Kinases; Tetrazoles; Up-Regulation; Vasoconstriction

2009
Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection.
    Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:8A

    Topics: Angiotensin II; Animals; Antioxidants; Cell Death; Cells, Cultured; Cytoprotection; Diabetes Mellitus, Experimental; Endoplasmic Reticulum; Humans; Metallothionein; Mice; Mice, Transgenic; Molecular Chaperones; Myocardium; Rats; Stress, Physiological; Tunicamycin; Up-Regulation

2009
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.
    Atherosclerosis, 2009, Volume: 207, Issue:2

    Topics: Angioplasty, Balloon; Angiotensin II; Animals; Binding Sites; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Cilostazol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hyperplasia; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Tetrazoles; Transcriptional Activation; Transforming Growth Factor beta; Tunica Intima

2009
Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes.
    Journal of pharmacological sciences, 2009, Volume: 110, Issue:4

    Topics: Angiotensin II; Animals; Blood Glucose; Chymases; Cricetinae; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Malondialdehyde; Peptidyl-Dipeptidase A; Streptozocin; Sulfonamides; Thiophenes; Time Factors

2009
[Establishment of a diabetic-hypertensive rat model].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2009, Volume: 44, Issue:6

    Topics: Angiotensin II; Angiotensinogen; Animals; Aorta; Blood Pressure Determination; Diabetes Mellitus, Experimental; Endothelin-1; Hypertension; Kidney; Male; Rats; Rats, Wistar

2009
Early diabetes in WKY and SHR produces decrease of the responses to angiotensin II and 5-HT and changes in the NO-GMPc pathway.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2009, Volume: 31, Issue:5

    Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Cyclic GMP; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Nitric Oxide; Nitroprusside; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin; Signal Transduction; Streptozocin; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents

2009
Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression.
    Molecular and cellular endocrinology, 2010, Feb-05, Volume: 315, Issue:1-2

    Topics: Angiotensin II; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose; Humans; Kidney; Male; Mesangial Cells; Prorenin Receptor; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Renin; RNA, Messenger

2010
Effect of pomegranate juice on Angiotensin II-induced hypertension in diabetic Wistar rats.
    Phytotherapy research : PTR, 2010, Volume: 24 Suppl 2

    Topics: Angiotensin II; Animals; Blood Pressure; Catalase; Colon; Diabetes Mellitus, Experimental; Fruit; Glutathione Reductase; Hypertension; Lythraceae; Male; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances

2010
Diabetes-associated alterations in volatile anesthetic actions on contractile response to norepinephrine in isolated mesenteric resistance arteries.
    Anesthesiology, 2010, Volume: 112, Issue:3

    Topics: Adrenomedullin; Anesthetics, Inhalation; Angiotensin II; Animals; Biological Factors; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Endothelins; Gap Junctions; In Vitro Techniques; Isoflurane; Isometric Contraction; Male; Methyl Ethers; Muscle, Smooth, Vascular; Nitric Oxide; Norepinephrine; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Serotonin; Sevoflurane; Splanchnic Circulation; Vascular Resistance; Vasoconstrictor Agents

2010
Critical role for osteopontin in diabetic nephropathy.
    Kidney international, 2010, Volume: 77, Issue:7

    Topics: Albuminuria; Angiotensin II; Animals; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Hypoglycemic Agents; Insulin; Kidney Glomerulus; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteopontin; PPAR gamma; Thiazolidinediones; Transforming Growth Factor beta

2010
Regulation of coronary arterial BK channels by caveolae-mediated angiotensin II signaling in diabetes mellitus.
    Circulation research, 2010, Apr-02, Volume: 106, Issue:6

    Topics: Angiotensin II; Animals; Caveolae; Caveolin 1; Coronary Vessels; CSK Tyrosine-Protein Kinase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gq-G11; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Mice; Mice, Knockout; Muscle, Smooth, Vascular; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Oxidation-Reduction; Patch-Clamp Techniques; Phosphorylation; Potassium; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; src-Family Kinases; Time Factors; Vasoconstriction

2010
Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrons; Peptidyl-Dipeptidase A; Phenotype; Receptor, Angiotensin, Type 1; Tetrazoles

2010
Add-on blockade of (pro)renin receptor in imidapril-treated diabetic SHRsp.
    Frontiers in bioscience (Elite edition), 2010, 06-01, Volume: 2, Issue:3

    Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Collagen Type I; Diabetes Mellitus, Experimental; Imidazolidines; Male; Organ Size; Prorenin Receptor; Rats; Rats, Inbred SHR; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta

2010
Angiotensin-(1-7) attenuates hyposmolarity-induced ANP secretion via the Na+-K+ pump.
    Peptides, 2010, Volume: 31, Issue:9

    Topics: Angiotensin I; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Heart; Heart Atria; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Nitric Oxide; Osmolar Concentration; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Stress, Physiological; Time Factors

2010
Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
    American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:4

    Topics: Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Female; Homeostasis; Hypertension; Kidney; Male; Muscle, Smooth, Vascular; Nephrons; Papaverine; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renin; Streptozocin; Vasodilator Agents

2010
Hyperglycemia limits experimental aortic aneurysm progression.
    Journal of vascular surgery, 2010, Volume: 52, Issue:4

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Hypoglycemic Agents; Insulin; Macrophages; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Pancreatic Elastase; Peritonitis; Thioglycolates; Time Factors; Ultrasonography; Vascular Endothelial Growth Factor A

2010
Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase.
    Kidney international, 2010, Volume: 78, Issue:9

    Topics: Albuminuria; Angiotensin II; Animals; Antioxidants; Bilirubin; Biliverdine; Blood Glucose; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Endothelial Cells; Glomerular Mesangium; Glucose; Humans; Hyperbilirubinemia, Hereditary; Male; Mice; Mice, Inbred C57BL; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Rats; Rats, Gunn; Superoxides; Time Factors; Transforming Growth Factor beta1

2010
Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade.
    Journal of hypertension, 2010, Volume: 28, Issue:11

    Topics: Albuminuria; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Kidney; Kidney Glomerulus; Male; Podocytes; Rats; Rats, Long-Evans; Remission Induction; Sclerosis; Treatment Outcome

2010
p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway.
    American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Diabetes Mellitus, Experimental; DNA, Mitochondrial; Gene Expression Regulation; Glucose; In Situ Nick-End Labeling; Kidney Tubules; L-Lactate Dehydrogenase; Malondialdehyde; Mice; Mice, Inbred ICR; Microscopy, Confocal; Mitochondria; NIMA-Interacting Peptidylprolyl Isomerase; Oxidative Stress; Peptidylprolyl Isomerase; Protein Kinase C; Protein Kinase C beta; Reactive Oxygen Species; RNA, Small Interfering; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1

2010
Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Volume: 300, Issue:2

    Topics: Adenoviridae; Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Gene Expression; Heart Rate; Kidney; Losartan; Male; NADPH Oxidases; Paraventricular Hypothalamic Nucleus; Phosphoproteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Superoxide Dismutase; Superoxides; Sympathetic Nervous System; Transduction, Genetic

2011
Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.
    American journal of physiology. Endocrinology and metabolism, 2011, Volume: 300, Issue:4

    Topics: Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Cadherins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Down-Regulation; Gene Expression Regulation; Hydroxyeicosatetraenoic Acids; Kidney Glomerulus; Male; Organ Size; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Streptozocin; Up-Regulation

2011
Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
    Free radical research, 2011, Volume: 45, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Benzoates; Collagen Type III; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hypertrophy; Intracellular Signaling Peptides and Proteins; Kidney; Mice; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; PPAR gamma; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Telmisartan; Transforming Growth Factor beta1; Up-Regulation

2011
Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes - role for Rho-kinase activation.
    British journal of pharmacology, 2011, Volume: 163, Issue:5

    Topics: Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Activation; Femoral Artery; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; rho-Associated Kinases; Vasoconstriction; Vasoconstrictor Agents

2011
Effect of pregnancy and diabetes on vascular receptors for angiotensin II.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2011, Volume: 33, Issue:3

    Topics: Angiotensin II; Animals; Aorta; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes, Gestational; Disease Models, Animal; Endothelium, Vascular; Female; Hypertension; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Risk Factors; Streptozocin; Vasoconstriction

2011
Activation of skin renin-angiotensin system in diabetic rats.
    Endocrine, 2011, Volume: 39, Issue:3

    Topics: Angiotensin II; Animals; Cells, Cultured; Collagen; Diabetes Mellitus, Experimental; Epidermis; Gene Expression; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; RNA, Messenger; Skin; Subcutaneous Fat

2011
Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage.
    American journal of physiology. Endocrinology and metabolism, 2011, Volume: 301, Issue:1

    Topics: Angiotensin II; Animals; Cells, Cultured; Diabetes Complications; Diabetes Mellitus, Experimental; Enzyme Activation; Humans; Lung; Male; Mice; NADPH Oxidases; Oxidative Stress; Pulmonary Fibrosis; Reactive Nitrogen Species; Signal Transduction; Streptozocin

2011
Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes.
    American journal of physiology. Cell physiology, 2011, Volume: 301, Issue:2

    Topics: Analysis of Variance; Angiotensin II; Animals; Antioxidants; Blood Glucose; Cell Shape; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Activators; Glucose; Humans; Male; Mesangial Cells; NADPH Oxidase 4; NADPH Oxidases; Oxidants; Oxidative Stress; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recombinant Fusion Proteins; RNA Interference; Signal Transduction; Time Factors; TRPC Cation Channels; TRPC6 Cation Channel

2011
Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy.
    Therapeutic advances in cardiovascular disease, 2011, Volume: 5, Issue:3

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dyslipidemias; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Lipids; Nitrates; Nitrites; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Time Factors; Ventricular Function, Left; Ventricular Pressure

2011
Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
    Journal of cardiovascular pharmacology, 2012, Volume: 59, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Autonomic Nervous System; Blood Glucose; Blood Pressure; Blotting, Western; Body Weight; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electrocardiography; Enalapril; Heart; Heart Rate; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Function, Left

2012
Angiotensin II-NADPH oxidase-derived superoxide mediates diabetes-attenuated cell excitability of aortic baroreceptor neurons.
    American journal of physiology. Cell physiology, 2011, Volume: 301, Issue:6

    Topics: Angiotensin II; Animals; Aorta; Baroreflex; Blotting, Western; Cyclic Nucleotide-Gated Cation Channels; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Male; NADPH Oxidases; Nodose Ganglion; Patch-Clamp Techniques; Potassium Channels; Pressoreceptors; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Superoxides

2011
Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats.
    Experimental neurology, 2011, Volume: 232, Issue:2

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Blood-Brain Barrier; Cerebral Hemorrhage; Cerebrovascular Circulation; Cholesterol, HDL; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Niacin; Rats; Rats, Wistar; Vasodilator Agents

2011
Angiotensin II type 2 receptor is critical for the development of human fetal pancreatic progenitor cells into islet-like cell clusters and their potential for transplantation.
    Stem cells (Dayton, Ohio), 2012, Volume: 30, Issue:3

    Topics: Angiotensin II; Animals; Cell Differentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Fetus; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Developmental; Gene Knockdown Techniques; Humans; Hyperglycemia; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Nude; Mitosis; ras Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stem Cells

2012
The role of reactive oxygen species in the modulation of the contraction induced by angiotensin II in carotid artery from diabetic rat.
    European journal of pharmacology, 2012, Mar-05, Volume: 678, Issue:1-3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Body Weight; Carotid Arteries; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Free Radical Scavengers; Male; NADP; NADPH Oxidases; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Vasoconstriction

2012
p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction.
    Circulation research, 2012, Feb-17, Volume: 110, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Binding Sites; Binding, Competitive; Cells, Cultured; Cyclic AMP Response Element Modulator; Diabetes Mellitus, Experimental; Enzyme Activation; MAP Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mitogen-Activated Protein Kinase 7; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Time Factors; Transfection; Ubiquitin-Protein Ligases

2012
Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.
    American journal of physiology. Renal physiology, 2012, Jun-01, Volume: 302, Issue:11

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Blood Pressure; Blotting, Western; C-Reactive Protein; Chromatography, High Pressure Liquid; Collagen; Diabetes Mellitus, Experimental; Female; Hypertension; Immunohistochemistry; Kidney; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; Sex Characteristics; Vascular Endothelial Growth Factor A

2012
Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats.
    Brain research, 2012, May-09, Volume: 1453

    Topics: Angiotensin II; Animals; Blood Glucose; Brain; Catalase; CD8 Antigens; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Inflammation; Intercellular Adhesion Molecule-1; Lymphocyte Function-Associated Antigen-1; Macrophages; Male; Monocytes; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Superoxides

2012
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
    Pharmacological research, 2012, Volume: 66, Issue:3

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury

2012
Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes.
    Journal of applied physiology (Bethesda, Md. : 1985), 2012, Volume: 113, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Bradykinin; Capsaicin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diterpenes; Heart; Kidney; Lidocaine; Losartan; Male; Norepinephrine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reflex; Sympathetic Nervous System; TRPV Cation Channels

2012
Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.
    Clinical science (London, England : 1979), 2012, Volume: 123, Issue:8

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aortic Diseases; Apoptosis; Biomarkers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Telemetry

2012
[Effects of two different extracts of total saponins from Cicer arietinum on kidney of T2DM rats].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2012, Volume: 47, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Blood Glucose; Blood Urea Nitrogen; Cicer; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelin-1; Glutathione Peroxidase; Hypoglycemic Agents; Insulin; Kidney; Male; Malondialdehyde; Plants, Medicinal; Random Allocation; Rats; Rats, Wistar; Saponins; Superoxide Dismutase; Thromboxane B2

2012
Sex-specific programming of hypertension in offspring of late-gestation diabetic rats.
    Pediatric research, 2012, Volume: 72, Issue:4

    Topics: Age Factors; Angiotensin II; Animals; Baroreflex; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes, Gestational; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Ganglionic Blockers; Gestational Age; Heart Rate; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase; Phenotype; Pregnancy; Rats; Rats, Sprague-Dawley; Sex Factors; Signal Transduction; Streptozocin; Superoxide Dismutase; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2012
Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes.
    Diabetes, 2012, Volume: 61, Issue:11

    Topics: Angiotensin II; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelium; Exenatide; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-raf; Receptors, Glucagon; RNA Interference; Signal Transduction; Tissue Culture Techniques; Venoms

2012
Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.
    American journal of physiology. Renal physiology, 2013, Mar-01, Volume: 304, Issue:5

    Topics: Adenosine A1 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Kidney; Male; Rats; Receptor, Adenosine A1; Renal Circulation; Tetrazoles; Vascular Resistance; Xanthines

2013
Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2013, Volume: 45, Issue:5

    Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Kidney; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Time Factors; Transforming Growth Factor beta

2013
[Protective effect of perindopril on dysfunction of endothelium-dependent relaxation in diabetic rats].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2000, Apr-28, Volume: 25, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Endothelium, Vascular; Male; Perindopril; Rats; Rats, Sprague-Dawley; Vasodilation

2000
Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension.
    Kidney international. Supplement, 2002, Issue:82

    Topics: Angiotensin II; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Male; Oligopeptides; Oxazoles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Endothelin; Receptors, Thromboxane A2, Prostaglandin H2; Renal Circulation; Thromboxane A2; Vascular Resistance; Vasoconstriction

2002
Role of thromboxane, catecholamines and endothelin-1 in the renal constrictor response to angiotensin II in diabetic hypertensive rats.
    Proceedings of the Western Pharmacology Society, 2002, Volume: 45

    Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Catecholamines; Diabetes Mellitus, Experimental; Endothelin-1; Hypertension, Renal; In Vitro Techniques; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Thromboxanes; Vasoconstrictor Agents

2002
Attenuated arterial and venous constriction in conscious rats with streptozotocin-induced diabetes.
    European journal of pharmacology, 2003, Jan-05, Volume: 458, Issue:3

    Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Consciousness; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Heart Rate; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Vasoconstriction; Veins

2003
Effect of blockade of endogenous angiotensin II on baroreflex function in conscious diabetic rats.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:5

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Consciousness; Diabetes Mellitus, Experimental; Enalapril; Heart Rate; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System

2003
[Changes of ultrastructure and function of the aortic endothelium in streptozotocin-diabetic rats and effect of perindopril].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2001, Feb-28, Volume: 26, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Diabetes Mellitus, Experimental; Endothelin-1; Endothelium, Vascular; Male; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley

2001
Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
    Heart and vessels, 2003, Volume: 18, Issue:1

    Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hepatocyte Growth Factor; Immunohistochemistry; Isoquinolines; Male; Muscle, Smooth; Proto-Oncogene Proteins c-met; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines

2003
Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes.
    The Journal of physiology, 2003, Jul-15, Volume: 550, Issue:Pt 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Electric Stimulation; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Female; In Vitro Techniques; Male; Membrane Potentials; Myocytes, Cardiac; Ovariectomy; Patch-Clamp Techniques; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Tetrahydroisoquinolines

2003
Influence of plasma insulin levels on antinatriuretic and vasoconstrictor actions of angiotensin-II.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2003, Volume: 25, Issue:4

    Topics: Angiotensin II; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diuresis; Drug Interactions; Enzyme Inhibitors; Ganglionic Blockers; Heart Rate; Hypoglycemic Agents; Insulin; Kidney; Natriuresis; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Streptozocin; Tetrazoles; Vasoconstrictor Agents

2003
Microvascular reactivity in experimental diabetes: responses of male and female rats.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2003, Volume: 52, Issue:5

    Topics: Acetylcholine; Angiotensin II; Animals; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Estrous Cycle; Female; Histamine; Hypoglycemic Agents; Insulin; Male; Microcirculation; Nitroprusside; Norepinephrine; Organ Size; Platelet Activating Factor; Rats; Rats, Wistar; Sex Characteristics; Uterus; Vasoconstrictor Agents; Vasodilator Agents

2003
Control of arterial pressure by angiotensin II and nitric oxide at the onset of diabetes.
    American journal of hypertension, 2003, Volume: 16, Issue:7

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Enalapril; Hypertension; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents

2003
Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells.
    American journal of physiology. Renal physiology, 2003, Volume: 285, Issue:6

    Topics: Angiotensin II; Animals; Antibodies; Aorta; Calcium; Calcium Channels; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypertrophy; Inositol 1,4,5-Trisphosphate Receptors; Kidney Glomerulus; Microcirculation; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Cytoplasmic and Nuclear; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Vasoconstriction; Vasoconstrictor Agents

2003
Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta.
    British journal of pharmacology, 2003, Volume: 140, Issue:2

    Topics: Angiotensin II; Animals; Aorta; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Gene Expression Regulation; Insulin; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Male; Norepinephrine; Organ Culture Techniques; Potassium; Rats; Rats, Wistar; Receptor, IGF Type 1; RNA, Messenger; Vasoconstriction

2003
Insulin and losartan reduce proteinuria and renal hypertrophy in the pregnant diabetic rat.
    The Journal of laboratory and clinical medicine, 2003, Volume: 142, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Female; Hypertrophy; Hypoglycemic Agents; Insulin; Kidney; Losartan; Peptidyl-Dipeptidase A; Pregnancy; Pregnancy in Diabetics; Proteinuria; Rats

2003
Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems.
    Acta diabetologica, 2003, Volume: 40, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Enalapril; Losartan; Norepinephrine; Rats; Rats, Wistar; Renin-Angiotensin System; Time Factors; Vasoconstriction

2003
Transgenic overexpression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes.
    The Journal of endocrinology, 2004, Volume: 180, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Body Weight; Calcium; Cells, Cultured; Diabetes Mellitus, Experimental; Gene Expression; Heart Ventricles; Insulin-Like Growth Factor I; Isoproterenol; Male; Mice; Mice, Inbred Strains; Mice, Transgenic; Models, Animal; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Organ Size; Phenylephrine

2004
Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Gene Expression; Imidazoles; Immunohistochemistry; Male; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Retina; Vascular Endothelial Growth Factor A

2004
[ATP-sensitive potassium channels and changes in their functional activity during streptozocin-induced diabetes mellitus].
    Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2003, Volume: 49, Issue:6

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Endothelium, Vascular; Male; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Potassium Channels; Rats; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents

2003
Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
    Experimental & molecular medicine, 2004, Feb-29, Volume: 36, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Humans; Imidazoles; Kidney Glomerulus; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Vascular Endothelial Growth Factor A

2004
Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Action Potentials; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Conductivity; Enzyme Inhibitors; Female; Genistein; Indoles; Male; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Protein Kinase C; Protein-Tyrosine Kinases; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Signal Transduction; Tetrahydroisoquinolines; Thionucleotides

2004
Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload.
    Journal of hypertension, 2004, Volume: 22, Issue:6

    Topics: Adrenomedullin; Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Diabetes Mellitus, Experimental; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Peptides; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Up-Regulation

2004
Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.
    Journal of hypertension, 2004, Volume: 22, Issue:8

    Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Fluid; Kidney; Losartan; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan

2004
Tempol augments angiotensin II-induced AT2 receptor-mediated relaxation in diabetic rat thoracic aorta.
    Journal of hypertension, 2004, Volume: 22, Issue:11

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antioxidants; Aorta, Thoracic; Blood Pressure; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Drug Synergism; Enzyme Inhibitors; Hyperglycemia; Male; NG-Nitroarginine Methyl Ester; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Spin Labels; Superoxide Dismutase; Tritium; Vasoconstrictor Agents; Vasodilation

2004
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.
    The Journal of clinical investigation, 2004, Volume: 114, Issue:8

    Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Antibodies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Kidney; Peptides; Protein Conformation; Protein Precursors; Protein Structure, Tertiary; Rats; Renin; Renin-Angiotensin System; Urine

2004
High glucose concentration augments angiotensin II mediated contraction via AT1 receptors in rat thoracic aorta.
    Pharmacological research, 2004, Volume: 50, Issue:6

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Synergism; Glucose; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Vasoconstriction

2004
[The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2004, Volume: 40, Issue:11

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Mice; Random Allocation; Tetrazoles; Valine; Valsartan; Vascular Endothelial Growth Factor A

2004
AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
    Cardiovascular research, 2005, Feb-01, Volume: 65, Issue:2

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Membrane; Depression, Chemical; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; In Vitro Techniques; Isradipine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nimodipine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1

2005
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Kidney international, 2005, Volume: 67, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Glucose; Imidazoles; Kidney; Kidney Glomerulus; Male; Mice; Rats; Streptozocin; Tetrazoles; Tumor Suppressor Proteins

2005
A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
    American journal of physiology. Renal physiology, 2005, Volume: 288, Issue:6

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Glucose; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Glomerulus; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley

2005
Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II.
    Diabetes, 2005, Volume: 54, Issue:4

    Topics: Amidohydrolases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diabetes Mellitus, Experimental; Enalapril; Liver; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Sulfotransferases

2005
In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker.
    Biochemical and biophysical research communications, 2005, May-06, Volume: 330, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Diabetes Mellitus, Experimental; Electron Spin Resonance Spectroscopy; Kidney; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Receptors, Angiotensin

2005
Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.
    American journal of hypertension, 2005, Volume: 18, Issue:4 Pt 1

    Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Extracellular Fluid; Kidney; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Thromboxane B2; Valine; Valsartan

2005
Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.
    British journal of pharmacology, 2005, Volume: 145, Issue:6

    Topics: Angiotensin II; Animals; Carbachol; Cell Line; Diabetes Mellitus, Experimental; Endothelin-1; ErbB Receptors; Female; Genistein; Histamine; Humans; In Vitro Techniques; Mesenteric Arteries; Mesenteric Veins; Norepinephrine; Quinazolines; Rats; Rats, Wistar; Signal Transduction; Streptozocin; Tyrphostins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2005
Effect of des-aspartate-angiotensin I on the actions of angiotensin II in the isolated renal and mesenteric vasculature of hypertensive and STZ-induced diabetic rats.
    Regulatory peptides, 2005, Jul-15, Volume: 129, Issue:1-3

    Topics: Angiotensin Amide; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blood Vessels; Diabetes Mellitus, Experimental; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Splanchnic Circulation; Vasoconstrictor Agents

2005
Renoprotective effect of benazepril on diabetic nephropathy mediated by P42/44MAPK.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2005, Volume: 25, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Function Tests; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Protective Agents; Random Allocation; Rats; Rats, Wistar

2005
Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat.
    The Journal of physiology, 2005, Aug-15, Volume: 567, Issue:Pt 1

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cells, Cultured; Diabetes Mellitus, Experimental; Female; Heart Ventricles; Hyperglycemia; Male; Membrane Potentials; Myocytes, Cardiac; Oxidative Stress; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Sex Characteristics; Superoxides

2005
Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes.
    Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:7

    Topics: Angiotensin II; Animals; Antioxidants; Diabetes Mellitus, Experimental; Heart Ventricles; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Insulin; Male; Oxidative Stress; Rats; Rats, Wistar

2005
Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:8

    Topics: Angiotensin II; Animals; Apoptosis; Cyclosporine; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Islets of Langerhans; Kidney; Osteopontin; Pancreatic Diseases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sialoglycoproteins; Thiazolidinediones; Transforming Growth Factor beta; Transforming Growth Factor beta1

2005
Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:5

    Topics: Amidines; Angiotensin II; Animals; Benzylamines; Blood Pressure; Blotting, Western; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Heart Rate; Hemodynamics; Immunohistochemistry; Male; Methoxamine; Neurotensin; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Vascular Diseases; Vasoconstrictor Agents

2005
Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    The Japanese journal of veterinary research, 2005, Volume: 53, Issue:1-2

    Topics: Angiotensin II; Angiotensinogen; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Immunohistochemistry; Insulin; Kidney; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Inbred MRL lpr; Organ Size; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Specific Pathogen-Free Organisms; Up-Regulation

2005
Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Kidney international. Supplement, 2005, Issue:99

    Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enalapril; Gene Expression Regulation; Kidney Cortex; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha

2005
Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells.
    Nephron. Experimental nephrology, 2006, Volume: 103, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Cell Cycle; Cell Line; Cells, Cultured; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Humans; Hypertrophy; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Irbesartan; Kidney; Kidney Tubules, Proximal; Male; Rats; Rats, Sprague-Dawley; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles

2006
Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes.
    Life sciences, 2006, Jun-06, Volume: 79, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Body Weight; Cardiovascular System; Diabetes Mellitus, Experimental; Drinking; Elastin; Extracellular Space; Fibrosis; Heart Ventricles; Hemodynamics; Male; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides

2006
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells.
    American journal of physiology. Renal physiology, 2006, Volume: 291, Issue:1

    Topics: Angiotensin II; Animals; Anticholesteremic Agents; Blood Glucose; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Janus Kinase 2; Male; Mesangial Cells; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; rho GTP-Binding Proteins; Signal Transduction; Simvastatin; STAT1 Transcription Factor; STAT3 Transcription Factor; Terpenes

2006
[Protective effects of Huanglian Jiedu decoction on vascular endothelial function in type 2 diabetic rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2005, Volume: 30, Issue:22

    Topics: Angiotensin II; Animals; Blood Glucose; Cholesterol; Cholesterol, HDL; Coptis; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Endothelium, Vascular; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Male; Nitric Oxide; Plants, Medicinal; Rats; Rats, Wistar; Triglycerides; von Willebrand Factor

2005
ANG II enhances contractile responses via PI3-kinase p110 delta pathway in aortas from diabetic rats with systemic hyperinsulinemia.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Blotting, Western; Class I Phosphatidylinositol 3-Kinases; Diabetes Mellitus, Experimental; Hyperinsulinism; Insulin; Isometric Contraction; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Phosphatidylinositol 3-Kinases; Rats; Rats, Wistar; Signal Transduction

2006
Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling.
    Kidney international, 2006, Volume: 69, Issue:6

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Gene Expression Profiling; Glucose; Glycoproteins; Kidney Tubules, Proximal; Male; Oligonucleotide Array Sequence Analysis; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Inbred BB; Rats, Wistar; Reactive Oxygen Species; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation

2006
Edaravone attenuates hydroxyl radical stress and augmented angiotensin II response in diabetic rats.
    Pharmacological research, 2006, Volume: 54, Issue:1

    Topics: Angiotensin II; Animals; Antipyrine; Aorta, Thoracic; Blood Pressure; Catalase; Diabetes Mellitus, Experimental; Edaravone; Free Radical Scavengers; Hydrogen Peroxide; Hydroxyl Radical; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; tert-Butylhydroperoxide; Vasoconstriction

2006
Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
    Diabetes, 2006, Volume: 55, Issue:6

    Topics: Adenoviridae; Angiotensin II; Animals; Blood Glucose; Blotting, Western; Body Weight; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Eye Proteins; Fibronectins; Genetic Therapy; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Metalloproteases; Nerve Growth Factors; Proteinuria; Rats; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Smad3 Protein; Streptozocin; Transforming Growth Factor beta1

2006
Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
    Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:7

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazolidines; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinases; Phosphorylation; Prorenin Receptor; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin; Renin-Angiotensin System

2006
Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat.
    European journal of pharmacology, 2006, Jul-10, Volume: 541, Issue:1-2

    Topics: Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Blotting, Western; Body Weight; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Pressure; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Tyrosine

2006
Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
    Laboratory investigation; a journal of technical methods and pathology, 2006, Volume: 86, Issue:9

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Butadienes; Cell Line; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Glomerular Mesangium; Imidazoles; Male; Mesangial Cells; Nitriles; Phosphorylation; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Signal Transduction; Smad1 Protein; src-Family Kinases; Tetrazoles

2006
The parathyroid hormone-related protein system and diabetic nephropathy outcome in streptozotocin-induced diabetes.
    Kidney international, 2006, Volume: 69, Issue:12

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blotting, Western; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Gene Expression Regulation; Hypertrophy; Immunohistochemistry; Kidney Tubules; Losartan; Mesangial Cells; Mice; Mice, Transgenic; Parathyroid Hormone-Related Protein; Podocytes; Receptor, Parathyroid Hormone, Type 1

2006
Role of angiotensin II in retinal leukostasis in the diabetic rat.
    Experimental eye research, 2006, Volume: 83, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Concanavalin A; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Leukocyte Common Antigens; Leukostasis; Losartan; Male; Nifedipine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ramipril; Rats; Rats, Long-Evans; Retina; Retinal Diseases

2006
Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium".
    Circulation, 2006, Oct-24, Volume: 114, Issue:17

    Topics: Angiotensin II; Angiotensinogen; Animals; Anti-Arrhythmia Agents; Buffers; Captopril; Diabetes Complications; Diabetes Mellitus, Experimental; Diffusion; Free Radical Scavengers; Imidazoles; Kallikreins; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Perfusion; Rats; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 90-kDa; Species Specificity; Tetrazoles

2006
Hydrogen peroxide modulates angiotensin II-induced contraction of mesenteric arteries from streptozotocin-induced diabetic rats.
    Vascular pharmacology, 2007, Volume: 46, Issue:3

    Topics: Angiotensin II; Animals; Catalase; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Hydrogen Peroxide; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Streptozocin; Superoxide Dismutase; Vascular Resistance

2007
Blood pressure early in diabetes depends on a balance between glomerular filtration rate and the renin-angiotensin system.
    American journal of hypertension, 2006, Volume: 19, Issue:12

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Disease Models, Animal; Glomerular Filtration Rate; Kidney; Male; Natriuresis; Nephrectomy; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sodium; Time Factors

2006
Vascular reactivity in arterioles from normal and alloxan-diabetic mice: studies on single perfused islets.
    Diabetes, 2007, Volume: 56, Issue:1

    Topics: Angiotensin II; Animals; Arterioles; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Potassium Chloride; Reference Values

2007
Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.
    Diabetes, 2007, Volume: 56, Issue:1

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Hydrogen Peroxide; Hyperglycemia; Mice; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Superoxides; Tetrazoles; Vasodilation

2007
Enalapril improves impairment of SERCA-derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta.
    European journal of pharmacology, 2007, Feb-05, Volume: 556, Issue:1-3

    Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Enalapril; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thapsigargin; Tyrosine

2007
[Effects of losartan on the levels of angiotensin II and its type-1 receptor in diabetic rat kidney].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2006, Volume: 26, Issue:12

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Immunoassay; Kidney; Losartan; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2006
Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
    European journal of pharmacology, 2007, Apr-30, Volume: 561, Issue:1-3

    Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypertension; Kidney; Male; Nitric Oxide; Peptide Fragments; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Renal Circulation; Splanchnic Circulation; Streptozocin

2007
Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
    Clinical and experimental nephrology, 2007, Volume: 11, Issue:1

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, Transforming Growth Factor beta; Renin-Angiotensin System; Signal Transduction; Smad Proteins; Transforming Growth Factor beta

2007
Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2007, Volume: 8, Issue:1

    Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Hypoglycemic Agents; Insulin; Kidney; Male; Molecular Weight; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Rats; Rats, Wistar; Renin-Angiotensin System

2007
Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Atrasentan; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme Activation; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Male; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Pyrrolidines; Rats; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Time Factors; Tyrphostins; Vasodilation

2007
ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.
    Kidney international, 2007, Volume: 72, Issue:5

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazoles; Kidney Glomerulus; Leucine; Mice; Peptidyl-Dipeptidase A; Streptozocin; Up-Regulation

2007
A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II.
    The American journal of pathology, 2007, Volume: 171, Issue:3

    Topics: Angiotensin II; Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Fibrosis; Hemodynamics; Humans; Male; Myocardium; Peptides; Rats; Rats, Inbred WKY; Smad2 Protein; Thrombospondin 1; Transforming Growth Factor beta

2007
Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum.
    Pharmacological research, 2007, Volume: 56, Issue:3

    Topics: Aging; Angiotensin I; Angiotensin II; Animals; Carbachol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erectile Dysfunction; Large-Conductance Calcium-Activated Potassium Channels; Male; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Penis; Peptide Fragments; Peptides; Potassium Channel Blockers; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents

2007
Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2007, Volume: 293, Issue:4

    Topics: Acetophenones; Acetylcysteine; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Imidazoles; Indoles; Leukostasis; Losartan; Male; NADPH Oxidases; Pyridines; Pyrroles; Rats; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Retinal Diseases; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents

2007
Downregulation of TRPC6 protein expression by high glucose, a possible mechanism for the impaired Ca2+ signaling in glomerular mesangial cells in diabetes.
    American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:4

    Topics: Angiotensin II; Animals; Calcium Channels; Calcium Signaling; Cells, Cultured; Diabetes Mellitus, Experimental; Down-Regulation; Glucose; Humans; Male; Mesangial Cells; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; TRPC Cation Channels; TRPC6 Cation Channel

2007
Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2007, Volume: 8, Issue:2

    Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Heart; Insulin; Losartan; Myocardial Infarction; Organ Size; Rats; Receptor Cross-Talk; Receptor, Insulin; Receptors, Angiotensin; Reference Values

2007
Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
    Current eye research, 2007, Volume: 32, Issue:10

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Capillaries; Captopril; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Hyperglycemia; Leukostasis; Losartan; Male; Rats; Rats, Inbred Lew; Retina; Retinal Vessels; Vascular Cell Adhesion Molecule-1

2007
Impaired angiotensin II AT(1) receptor function and enhanced Na, K-ATPase affinity for sodium in proximal tubule of streptozotocin-treated diabetic rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2007, Volume: 29, Issue:7

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Gene Expression; GTP-Binding Proteins; Kidney Tubules, Proximal; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium; Sodium-Potassium-Exchanging ATPase; Streptozocin; Vasoconstrictor Agents

2007
Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Translational research : the journal of laboratory and clinical medicine, 2007, Volume: 150, Issue:6

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Filtration Rate; Hemodynamics; Kidney Function Tests; Male; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Streptozocin; Vascular Resistance; Vasoconstriction; Vasodilation

2007
Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:3

    Topics: Amides; Angiotensin II; Animals; Arterioles; C-Peptide; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Norepinephrine; Potassium Chloride; Pyridines; Rho Factor; rho-Associated Kinases; Vasoconstriction; Vasoconstrictor Agents

2008
Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.
    Brain research, 2008, May-13, Volume: 1209

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Cerebral Arteries; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Superoxides; Vasodilation

2008
The collecting duct is the major source of prorenin in diabetes.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertension, Renal; Imidazoles; Immunohistochemistry; Juxtaglomerular Apparatus; Kidney Tubules, Collecting; Microscopy, Fluorescence; Quinacrine; Rats; Rats, Wistar; Renin; Tetrazoles; Trypsin; Vasoconstrictor Agents

2008
Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart.
    British journal of pharmacology, 2008, Volume: 154, Issue:3

    Topics: Aldosterone; Angiotensin II; Animals; Autocrine Communication; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Ethidium; Female; Male; Myocytes, Cardiac; Oxidative Stress; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Sex Factors; Superoxides

2008
Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:1

    Topics: Acetates; Angiotensin II; Animals; Antibodies; Benzodiazepinones; Blood Glucose; Blood Pressure; Cells, Cultured; Collagen Type I; Diabetes Mellitus, Experimental; Elasticity; Fibrosis; Hypertension; Integrin alphaVbeta3; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Microcirculation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; RNA Interference; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1

2008
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.
    Diabetes, 2008, Volume: 57, Issue:8

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus, Experimental; Extracellular Signal-Regulated MAP Kinases; Immunoblotting; Mice; Mice, Inbred C57BL; Neurons; Oncogene Protein v-akt; Phosphorylation; Receptor, Angiotensin, Type 1; Retina; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; STAT3 Transcription Factor; Synaptophysin; Telmisartan; Tetrazoles; Ubiquitination; Valine; Valsartan

2008
Aldosterone responses to angiotensin II, adrenocorticotropin, and potassium in chronic experimental diabetes mellitus in rats.
    Endocrinology, 1984, Volume: 115, Issue:6

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Chronic Disease; Diabetes Mellitus, Experimental; Insulin; Male; Potassium; Potassium Chloride; Rats; Rats, Inbred Strains; Renin; Streptozocin

1984
Glucoprivic feeding is impaired by lateral or fourth ventricular alloxan injection.
    The American journal of physiology, 1982, Volume: 243, Issue:3

    Topics: Alloxan; Angiotensin II; Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Drinking; Eating; Injections, Intraventricular; Insulin Antagonists; Male; Rats; Rats, Inbred Strains; Streptozocin

1982
Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat.
    The American journal of physiology, 1984, Volume: 247, Issue:1 Pt 2

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Insulin; Kidney Glomerulus; Male; Potassium; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Cell Surface; Renin-Angiotensin System; Sodium; Sodium Chloride; Time Factors

1984
Influence of streptozotocin-induced diabetes on blood pressure and on renin formation and release.
    Naunyn-Schmiedeberg's archives of pharmacology, 1980, Volume: 313, Issue:3

    Topics: Adrenal Medulla; Angiotensin II; Animals; Blood Pressure; Catecholamines; Diabetes Mellitus, Experimental; Female; Kidney Cortex; Rats; Renin

1980
Vascular responsiveness and serum biochemical parameters in alloxan diabetes mellitus.
    The American journal of physiology, 1980, Volume: 239, Issue:6

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Glucose; Cholesterol; Creatinine; Diabetes Mellitus, Experimental; Electrolytes; Male; Muscle, Smooth, Vascular; Norepinephrine; Portal Vein; Potassium; Rats; Triglycerides; Vasoconstriction

1980
Renin response to 12-hydroxyeicosatetraenoic acid is increased in diabetic rats.
    Diabetes, 1995, Volume: 44, Issue:3

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Hydroxyeicosatetraenoic Acids; Iloprost; In Vitro Techniques; Kidney Cortex; Male; Rats; Rats, Sprague-Dawley; Reference Values; Renin

1995
Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Journal of hypertension, 1995, Volume: 13, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Losartan; Male; Organ Size; Random Allocation; Rats; Rats, Inbred SHR; Tetrazoles

1995
Baroreflex function in streptozotocin (STZ) induced diabetic rats.
    Diabetes research and clinical practice, 1995, Volume: 27, Issue:1

    Topics: Analysis of Variance; Angiotensin II; Animals; Baroreflex; Blood Pressure; Diabetes Mellitus, Experimental; Enalapril; Heart Rate; Kidney; Male; Rats; Rats, Sprague-Dawley; Reference Values; Sympathetic Nervous System; Vasopressins

1995
Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction.
    Journal of the American Society of Nephrology : JASN, 1995, Volume: 5, Issue:10

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diet, Sodium-Restricted; Hemodynamics; Kidney; Male; Rats; Rats, Inbred Strains; Renal Circulation

1995
Fructose loading induces cardiovascular and metabolic changes in nondiabetic and diabetic rats.
    Canadian journal of physiology and pharmacology, 1994, Volume: 72, Issue:7

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Drinking; Eating; Fructose; Glucose Tolerance Test; Hemodynamics; Insulin; Male; Pulse; Rats; Rats, Wistar; Triglycerides

1994
The cardiac renin-angiotensin system in STZ-induced diabetes.
    Diabetes, 1994, Volume: 43, Issue:10

    Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Gene Expression; Hyperglycemia; Imidazoles; Insulin; Kinetics; Losartan; Male; Myocardium; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Renin-Angiotensin System; RNA, Messenger; Tetrazoles

1994
Angiotensin responsiveness in hyperfiltering and nonhyperfiltering diabetic rats.
    Journal of the American Society of Nephrology : JASN, 1993, Volume: 4, Issue:6

    Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Insulin; Male; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Time Factors; Vascular Resistance

1993
The renin-angiotensin system in the type II diabetic obese Zucker rat.
    Journal of the American Society of Nephrology : JASN, 1993, Volume: 4, Issue:6

    Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; In Vitro Techniques; Male; Norepinephrine; Obesity; Rats; Rats, Zucker; Renin; Renin-Angiotensin System; Vasoconstriction

1993
Dose-response differences in the ability of ramipril to improve retention in diabetic mice.
    European journal of pharmacology, 1993, Aug-24, Volume: 240, Issue:2-3

    Topics: Angiotensin I; Angiotensin II; Animals; Avoidance Learning; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Mice; Ramipril; Retention, Psychology

1993
Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
    Diabetologia, 1993, Volume: 36, Issue:12

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Motor Neurons; Neural Conduction; Neurons, Afferent; Peripheral Nerves; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Regional Blood Flow; Sciatic Nerve

1993
Abnormality of the glomerular angiotensin II receptor in experimental diabetic nephropathy.
    Clinical and experimental pharmacology & physiology, 1993, Volume: 20, Issue:5

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerulonephritis, IGA; Hypertension; Kidney Glomerulus; Radioimmunoassay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin

1993
Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: effects of insulin or aldose reductase inhibition.
    British journal of pharmacology, 1993, Volume: 109, Issue:4

    Topics: Aldehyde Reductase; Angiotensin II; Animals; Blood Glucose; Body Weight; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Endothelium, Vascular; Epoprostenol; In Vitro Techniques; Insulin; Lung; Male; Muscle Tonus; Muscle, Smooth, Vascular; Perfusion; Rats; Rats, Wistar; Sciatic Nerve

1993
Differential changes of adrenoceptor- and muscarinic receptor-linked prostacyclin synthesis by the aorta and urinary bladder of the diabetic rat.
    British journal of pharmacology, 1993, Volume: 108, Issue:4

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Arachidonic Acid; Body Weight; Calcimycin; Calcium-Transporting ATPases; Diabetes Mellitus, Experimental; Epoprostenol; In Vitro Techniques; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Phorbol 12,13-Dibutyrate; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Muscarinic; Terpenes; Thapsigargin; Urinary Bladder

1993
Effect of high-salt intake on blood pressure and vascular reactivity of diabetic rats.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1995, Volume: 28, Issue:8

    Topics: Analysis of Variance; Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Diabetes Mellitus, Experimental; Hypertension; Male; Norepinephrine; Rats; Rats, Wistar; Sodium, Dietary; Vasoconstrictor Agents

1995
Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats.
    Diabetologia, 1996, Volume: 39, Issue:3

    Topics: Albuminuria; Aminopeptidases; Angiotensin II; Animals; Blood Glucose; Blotting, Northern; Body Weight; Diabetes Mellitus, Experimental; Gene Expression; Glomerular Filtration Rate; Glutamyl Aminopeptidase; Immunohistochemistry; In Vitro Techniques; Insulin; Kidney; Kidney Glomerulus; Kinetics; Male; Organ Size; Rats; Rats, Wistar; Saralasin; Time Factors

1996
Opposite influences of hypertension and diabetes mellitus on pressor responses induced by different alpha-adrenoceptor agonists and angiotensin II in pithed rats.
    Blood pressure, 1996, Volume: 5, Issue:1

    Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Azepines; Blood Glucose; Blood Pressure; Brimonidine Tartrate; Clonidine; Decerebrate State; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypertension; Imidazoles; Male; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1996
Reduced renal microvascular reactivity to angiotensin II in diabetic rats.
    Microcirculation (New York, N.Y. : 1994), 1994, Volume: 1, Issue:2

    Topics: Angiotensin II; Animals; Arterioles; Capillary Resistance; Diabetes Mellitus, Experimental; Indomethacin; Kidney; Microcirculation; Microscopy, Video; Rats; Vasoconstriction; Vasoconstrictor Agents

1994
Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration.
    Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:1

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Nephrectomy; Nitric Oxide; Nitroarginine; Rats; Rats, Sprague-Dawley; Tetrazoles

1996
Influence of nifedipine on pressor responses induced by different alpha-adrenoceptor agonists and angiotensin II in pithed diabetic hypertensive rats.
    Journal of hypertension, 1996, Volume: 14, Issue:7

    Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Pressure; Brimonidine Tartrate; Calcium; Calcium Channel Blockers; Clonidine; Diabetes Mellitus, Experimental; Hypertension; Imidazoles; Nifedipine; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin

1996
Dietary myo-inositol restores diabetic renal arteriolar reactivity to angiotensin II but not to norepinephrine.
    Microcirculation (New York, N.Y. : 1994), 1996, Volume: 3, Issue:2

    Topics: Acetylcholine; Angiotensin II; Animals; Arterioles; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Carbohydrates; Female; Hydronephrosis; Inositol; Kidney; Membrane Lipids; Microcirculation; Norepinephrine; Phospholipids; Rats; Rats, Wistar; Renin; Streptozocin; Vasoconstriction; Vasoconstrictor Agents

1996
Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
    Investigative ophthalmology & visual science, 1996, Volume: 37, Issue:11

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Imidazoles; Isoenzymes; Lipoxygenase Inhibitors; Losartan; Male; Masoprocol; Peptidyl-Dipeptidase A; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Rats, Zucker; Retina; Sodium-Potassium-Exchanging ATPase; Tetrazoles; Vasoconstrictor Agents

1996
Altered vasoactivity in the early diabetic eye: measured in the isolated perfused rat eye.
    Experimental eye research, 1995, Volume: 61, Issue:6

    Topics: Angiotensin II; Animals; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dinoprost; Eye; Isoproterenol; Male; Optic Nerve; Phenylephrine; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Serotonin; Vascular Resistance; Vasoconstrictor Agents

1995
Enhanced renal sensitivity to angiotensin actions in diabetes mellitus in the rat.
    The American journal of physiology, 1996, Volume: 271, Issue:3 Pt 2

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Injections, Intra-Arterial; Injections, Intravenous; Kidney; Male; Rats; Rats, Inbred Strains; Renal Circulation

1996
Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.
    Diabetologia, 1996, Volume: 39, Issue:8

    Topics: Aldehyde Reductase; Angiotensin II; Animals; Arterioles; Blood Pressure; Cohort Studies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet; Disease Models, Animal; Enzyme Inhibitors; Galactitol; Galactose; Image Processing, Computer-Assisted; In Vitro Techniques; Kidney; Male; Muscle, Smooth, Vascular; Naphthalenes; Perfusion; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents

1996
Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes.
    Nephron, 1996, Volume: 74, Issue:1

    Topics: Angiotensin II; Animals; Arginine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renal Circulation; Time Factors

1996
Vascular reactivity to angiotensin II in blood-perfused kidneys of hypertensive diabetic rats.
    European journal of pharmacology, 1996, Aug-29, Volume: 310, Issue:2-3

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1996
Myocardial angiotensin II (Ang II) receptors in diabetic rats.
    Annals of the New York Academy of Sciences, 1996, Sep-30, Volume: 793

    Topics: Angiotensin II; Animals; Cell Membrane; Diabetes Mellitus, Experimental; Heart; Male; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin

1996
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
    Diabetes, 1997, Volume: 46, Issue:1

    Topics: Albuminuria; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, Sodium-Restricted; Glomerular Filtration Rate; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Reference Values; Regression Analysis; Renin; Time Factors

1997
p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats.
    Circulation research, 1997, Volume: 80, Issue:1

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Hydralazine; Imidazoles; In Situ Hybridization; Losartan; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase; Systole; Tetrazoles

1997
Alteration of cytosolic calcium induced by angiotensin II and norepinephrine in mesangial cells from diabetic rats.
    Kidney international, 1997, Volume: 51, Issue:1

    Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Cytosol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Mesangium; Glucose; Male; Norepinephrine; Rats; Rats, Wistar; Vasoconstrictor Agents

1997
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy.
    American journal of hypertension, 1997, Volume: 10, Issue:3

    Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Kidney; Nephrectomy; Pyrimidines; Rats; Rats, Wistar; Tetrazoles

1997
Effects of aminoguanidine and N(G)-nitro-L-arginine methyl ester on vascular responses of aortae and lungs from streptozotocin-diabetic rats.
    Prostaglandins, leukotrienes, and essential fatty acids, 1997, Volume: 56, Issue:4

    Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Guanidines; Lung; Male; NG-Nitroarginine Methyl Ester; Phenylephrine; Rats; Rats, Wistar; Vasodilation

1997
Cardiac hypertrophy in diabetic spontaneously hypertensive rats: role of angiotensin II?
    Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:6

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiac Volume; Cardiomegaly; Diabetes Mellitus, Experimental; Heart Septum; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred SHR

1997
Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat.
    Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:6

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Disease Models, Animal; Enalapril; Glucose; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred Strains; Tetrazoles; Verapamil

1997
Augmented Ca2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats.
    Atherosclerosis, 1997, Volume: 131, Issue:2

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Aorta, Thoracic; Blood Glucose; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cell Count; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Male; Muscle, Smooth, Vascular; Nicardipine; Rats; Rats, Wistar; Vasoconstrictor Agents; Verapamil

1997
Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
    Diabetologia, 1997, Volume: 40, Issue:7

    Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Insulin; Kidney; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Reference Values; Renin; RNA, Messenger; RNA, Ribosomal, 28S; Transcription, Genetic

1997
Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats.
    The Journal of endocrinology, 1997, Volume: 154, Issue:2

    Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensinogen; Animals; Diabetes Mellitus, Experimental; Insulin; Kidney; Liver; Male; Myocardium; Rats; Rats, Wistar; Receptors, Angiotensin; Renin

1997
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Diabetes, 1997, Volume: 46, Issue:10

    Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Glomerulus; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan

1997
Adrenal renin-angiotensin-aldosterone system in streptozotocin-diabetic rats.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1998, Volume: 30, Issue:1

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Electrolytes; Male; Rats; Rats, Wistar; Renin; Renin-Angiotensin System

1998
Constrictor responses of the rat basilar artery during diabetes mellitus.
    Brain research, 1998, Feb-09, Volume: 783, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Basilar Artery; Blood Pressure; Cerebrovascular Disorders; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Thromboxanes; Vasoconstriction; Vasoconstrictor Agents

1998
Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment.
    Diabetes, 1998, Volume: 47, Issue:6

    Topics: Acetylcholine; Angiotensin II; Animals; Arterioles; Blood Glucose; Blood Pressure; Consciousness; Cromakalim; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Glycated Hemoglobin; Guanidines; Male; Microcirculation; Muscle, Skeletal; Norepinephrine; Potassium Channels; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilator Agents

1998
Dietary n-3 fatty acids alter angiotensin-induced contraction and 1,2-diacylglycerol fatty acid composition in thoracic aortas from diabetic rats.
    Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 58, Issue:4

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Dietary Fats, Unsaturated; Diglycerides; Dose-Response Relationship, Drug; Fatty Acids; Fatty Acids, Omega-3; Male; Muscle Contraction; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Weaning

1998
Altered vasoreactivity to angiotensin II in experimental diabetic neuropathy: role of nitric oxide.
    Muscle & nerve, 1999, Volume: 22, Issue:7

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Logistic Models; Male; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasomotor System

1999
Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats.
    Kidney international, 1999, Volume: 56, Issue:1

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Blood Glucose; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Enzymes; Female; Hormones; Hypertension; Kidney; Mice; Organ Size; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reference Values; Renin

1999
Changes in angiotensin converting enzyme activity in the renal vascular bed of streptozotocin-induced diabetic rat.
    Research communications in molecular pathology and pharmacology, 1999, Volume: 104, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Drug Interactions; Kidney; Losartan; Male; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renal Artery; Streptozocin; Vasoconstriction

1999
Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus.
    American journal of physiology. Renal physiology, 2000, Volume: 278, Issue:2

    Topics: Angiotensin II; Animals; Arterioles; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Free Radical Scavengers; Glucose; Male; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Renal Circulation; Streptozocin; Superoxide Dismutase; Superoxides; Vasoconstriction; Vasoconstrictor Agents

2000
Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent.
    Laboratory investigation; a journal of technical methods and pathology, 2000, Volume: 80, Issue:4

    Topics: Angiotensin II; Animals; Apoptosis; Diabetes Mellitus, Experimental; Myocardium; Rats; Receptors, Angiotensin; Streptozocin

2000
Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.
    Kidney international, 2000, Volume: 58, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Hypertrophy; Hypoglycemic Agents; Insulin; Kidney Tubules, Proximal; Losartan; Male; Nephritis, Interstitial; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger

2000
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
    Diabetologia, 2000, Volume: 43, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Gene Expression; In Situ Hybridization; Lymphokines; Male; Perindopril; Ramipril; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000
Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus.
    Cardiovascular research, 2001, Aug-15, Volume: 51, Issue:3

    Topics: Angiotensin II; Animals; Blotting, Northern; Diabetes Mellitus, Experimental; Gene Expression Regulation; Kidney Cortex; Losartan; Male; Natriuretic Peptide, C-Type; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger

2001
Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic rats.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:11

    Topics: Angiotensin II; Animals; Aorta; Benzoquinones; Diabetes Mellitus, Experimental; Insulin; Leukotriene Antagonists; Leukotriene E4; Lipoxygenase Inhibitors; Male; Organ Culture Techniques; Potassium Chloride; Propionates; Quinolines; Rats; Rats, Wistar; SRS-A; Vasoconstriction; Vasoconstrictor Agents

2001
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
    The Journal of physiology, 2001, Nov-15, Volume: 537, Issue:Pt 1

    Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan

2001
Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2001, Volume: 2, Issue:3

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Female; Hypoglycemic Agents; Insulin; Kidney; Lung; Organ Size; Peptidyl-Dipeptidase A; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Pregnancy, Animal; Proteinuria; Rats; Rats, Wistar; Reference Values; Uterus

2001
Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2002, Volume: 282, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension, Renal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Sodium; Sympathetic Nervous System

2002
Renin-angiotensin system in phlorhizin compared with alloxan diabetes in the rat.
    Diabetes, 1979, Volume: 28, Issue:2

    Topics: Alloxan; Angiotensin II; Angiotensinogen; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Kidney; Male; Phlorhizin; Rats; Renin; Water-Electrolyte Balance

1979
Renin-angiotensin-aldosterone system in diabetes mellitus.
    Diabetes, 1976, Volume: 25, Issue:2 SUPPL

    Topics: Aldosterone; Angiotensin II; Animals; Blood Volume; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Diabetic Nephropathies; Diabetic Neuropathies; Humans; Hypertension; Hypotension, Orthostatic; Juxtaglomerular Apparatus; Models, Biological; Potassium; Rats; Renin; Sodium; Vascular Resistance; Water-Electrolyte Balance

1976
Altered regulation of renin secretion by insulinlike growth factors and angiotensin II in diabetic rats.
    Diabetes, 1992, Volume: 41, Issue:9

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Insulin; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Kidney; Male; Rats; Rats, Inbred Strains; Renin; Streptozocin

1992
Diabetic rat glomerular mesangial cells display normal inositol trisphosphate and calcium release.
    The American journal of physiology, 1992, Volume: 263, Issue:4 Pt 2

    Topics: Angiotensin II; Animals; Calcium; Calcium-Transporting ATPases; Cytosol; Diabetes Mellitus, Experimental; Electrophysiology; Glomerular Mesangium; Inositol 1,4,5-Trisphosphate; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Reference Values; Terpenes; Thapsigargin

1992
Increased microalbuminuria in diabetic rats is independent of angiotensin II or glomerular proteoglycan synthesis.
    Canadian journal of physiology and pharmacology, 1992, Volume: 70, Issue:8

    Topics: Albuminuria; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Histocytochemistry; Insulin; Kidney Glomerulus; Male; Polyethyleneimine; Proteoglycans; Rats; Rats, Sprague-Dawley

1992
Diabetes-induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine nucleotide regulatory protein Gi-2 in hepatocytes.
    The Biochemical journal, 1990, Oct-15, Volume: 271, Issue:2

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angiotensin II; Animals; Cell Membrane; Diabetes Mellitus, Experimental; Gene Expression; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Immunoblotting; Liver; Male; Molecular Weight; Nucleic Acid Hybridization; Phosphorylation; Rats; Rats, Inbred Strains; RNA; Tetradecanoylphorbol Acetate; Vasopressins

1990
Down-regulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats.
    Journal of cardiovascular pharmacology, 1991, Volume: 17 Suppl 7

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Down-Regulation; Endothelins; Isoquinolines; Kidney Glomerulus; Piperazines; Protein Kinase C; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, Endothelin

1991
Suppression of the renin-angiotensin system induced by streptozotocin treatment in neonatal spontaneously hypertensive rats.
    Japanese circulation journal, 1990, Volume: 54, Issue:2

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Ganglionic Blockers; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin-Angiotensin System; Streptozocin

1990
Streptozotocin-induced experimental diabetes causes a time-dependent inhibition of growth and steroidogenic capacity of rat adrenal zona glomerulosa.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1990, Volume: 190, Issue:1

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Captopril; Cell Nucleus; Dexamethasone; Diabetes Mellitus, Experimental; Endoplasmic Reticulum; Kinetics; Male; Mitochondria; Rats; Rats, Inbred Strains; Zona Glomerulosa

1990
Morphology and functional responses of isolated zona glomerulosa cells of streptozotocin-induced diabetic rats.
    Experimental pathology, 1990, Volume: 39, Issue:2

    Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Corticosterone; Diabetes Mellitus, Experimental; Hyperglycemia; Male; Microscopy, Electron; Potassium; Rats; Rats, Inbred Strains; Streptozocin; Zona Glomerulosa

1990
Effect of insulin on the cyclic AMP response of cultured glomerular mesangial cells.
    Biochemical Society transactions, 1989, Volume: 17, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Cells, Cultured; Cyclic AMP; Diabetes Mellitus, Experimental; Glomerular Mesangium; Insulin; Rats

1989
Guanine nucleotide binding regulatory proteins and adenylate cyclase in livers of streptozotocin- and BB/Wor-diabetic rats. Immunodetection of Gs and Gi with antisera prepared against synthetic peptides.
    The Journal of clinical investigation, 1989, Volume: 83, Issue:6

    Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aluminum; Angiotensin II; Animals; Catalysis; Cell Line; Cell Membrane; Cholera Toxin; Colforsin; Diabetes Mellitus, Experimental; Enzyme Activation; Fluorine; Glucagon; GTP-Binding Proteins; Guanosine Triphosphate; Immune Sera; Injections, Intraperitoneal; Liver; Male; Peptide Fragments; Pertussis Toxin; Rats; Rats, Inbred BB; Rats, Inbred Strains; Virulence Factors, Bordetella

1989
Renal vascular responses and eicosanoid release in diabetic rats.
    The American journal of physiology, 1989, Volume: 257, Issue:5 Pt 2

    Topics: Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Arginine Vasopressin; Blood Vessels; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Eicosanoids; Glucose; Insulin; Kidney; Male; Rats; Rats, Inbred Strains; Renal Circulation; Streptozocin; Time Factors

1989
Altered microvascular reactivity in streptozotocin-induced diabetes in rats.
    The American journal of physiology, 1989, Volume: 257, Issue:5 Pt 2

    Topics: Angiotensin II; Animals; Arteries; Arterioles; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Epoprostenol; Indomethacin; Male; Osmolar Concentration; Prostaglandins; Rats; Rats, Inbred Strains; Streptozocin

1989
Zona glomerulosa morphology and function in streptozotocin-induced diabetic rats.
    Endocrinology, 1988, Volume: 123, Issue:2

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Blood Glucose; Captopril; Dexamethasone; Diabetes Mellitus, Experimental; Endothelium; Male; Microscopy, Electron; Mitochondria; Potassium; Rats; Rats, Inbred Strains; Renin

1988
Effects of angiotensin II, adrenocorticotropin, and potassium on aldosterone production in adrenal zona glomerulosa cells from streptozotocin-induced diabetic rats.
    Endocrinology, 1986, Volume: 118, Issue:1

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Kinetics; Male; Potassium; Rats; Rats, Inbred Strains; Renin

1986
Comparison of glomerular and mesangial prostaglandin synthesis and glomerular contraction in two rat models of diabetes mellitus.
    Diabetes, 1987, Volume: 36, Issue:12

    Topics: Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Arginine Vasopressin; Calcimycin; Cells, Cultured; Diabetes Mellitus, Experimental; Dinoprostone; Kidney Glomerulus; Male; Norepinephrine; Prostaglandins E; Rats; Rats, Inbred BB; Rats, Inbred Strains; Reference Values

1987
Diabetes mellitus and hypertension. State of the art lecture.
    Hypertension (Dallas, Tex. : 1979), 1988, Volume: 11, Issue:2 Pt 2

    Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Humans; Hypertension; Hypertension, Renovascular; Kidney; Norepinephrine; Prazosin; Rats; Time Factors; Vasopressins

1988
Sodium restriction corrects hyperfiltration of diabetes.
    The American journal of physiology, 1988, Volume: 254, Issue:5 Pt 2

    Topics: Algorithms; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diet, Sodium-Restricted; Glomerular Filtration Rate; Hemodynamics; Kidney Glomerulus; Male; Natriuresis; Rats; Rats, Inbred Strains; Renin; Saralasin; Vascular Resistance

1988
Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats.
    The American journal of physiology, 1987, Volume: 253, Issue:5 Pt 2

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Captopril; Diabetes Mellitus, Experimental; Heart Rate; Male; Methoxamine; Pentolinium Tartrate; Pressoreceptors; Rats; Rats, Inbred Strains; Renin; Vasopressins

1987
Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats.
    Renal physiology, 1986, Volume: 9, Issue:3

    Topics: Aldosterone; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hematocrit; Male; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System

1986
Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanism.
    Endocrinology, 1987, Volume: 120, Issue:4

    Topics: Aldosterone; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Iodine Radioisotopes; Kidney Glomerulus; Kinetics; Magnesium; Magnesium Chloride; Male; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Renin

1987
A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit.
    British journal of pharmacology, 1987, Volume: 91, Issue:2

    Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; In Vitro Techniques; Male; Norepinephrine; Potassium Chloride; Rabbits; Rats; Rats, Inbred Strains; Serotonin; Species Specificity; Vasoconstriction

1987
Limited capacity for renal vasodilatation in anesthetized diabetic rats.
    The American journal of physiology, 1987, Volume: 253, Issue:4 Pt 2

    Topics: 3-O-Methylglucose; Acetylcholine; Angiotensin II; Animals; Bradykinin; Denervation; Diabetes Mellitus, Experimental; Extracorporeal Circulation; Hemodynamics; Kidney; Male; Methylglucosides; Nitroprusside; Norepinephrine; Rats; Rats, Inbred Strains; Regional Blood Flow; Vasodilation

1987
Impaired contractile responsiveness of diabetic glomeruli to angiotensin II: a possible indication of mesangial dysfunction in diabetes mellitus.
    Biochemical and biophysical research communications, 1986, May-14, Volume: 136, Issue:3

    Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Inulin; Kidney Glomerulus; Male; Muscle Contraction; Rats; Rats, Inbred Strains

1986
Cerebral cholinergic control of rat arterial blood pressure in streptozotocin-induced diabetes.
    Pharmacological research communications, 1986, Volume: 18, Issue:10

    Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Brain; Carbachol; Diabetes Mellitus, Experimental; Hemodynamics; Male; Parasympathetic Nervous System; Physostigmine; Rats; Rats, Inbred Strains

1986
Renin, angiotensin, and norepinephrine in alloxan diabetes.
    Diabetes, 1974, Volume: 23, Issue:12

    Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Blood Volume; Body Weight; Diabetes Mellitus, Experimental; Hematocrit; Insulin, Isophane; Kidney; Male; Norepinephrine; Potassium Isotopes; Radioimmunoassay; Radioisotopes; Rats; Renal Artery; Renin; Streptozocin; Tyramine

1974